"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,DE,B,DE 1293844 B,168-665-481-884-379,1969-04-30,1969,DE R0041844 A,1965-10-27,US 40668164 A;;US 46806865 A,1964-10-27,Digital und analog arbeitende logische Schaltung,,RCA CORP,BROOKS MARTIN THOMAS;;PATRICK MCGROGAN JUN ELWOOD,,https://lens.org/168-665-481-884-379,Patent Application,no,0,3,4,5,0,G06G7/25;;G06G7/25;;G06N3/04;;G06N3/04;;H03K19/00;;H03K19/00;;H03G11/002;;H03G11/002,G06G7/25;;G06N3/04;;H03G11/00;;H03K19/00,,1,0,,,None,DISCONTINUED
2,EP,A4,EP 3612140 A4,080-052-097-282-661,2021-05-12,2021,EP 18787294 A,2018-04-18,US 201762488405 P;;US 2018/0028107 W,2017-04-21,"DEPLOYABLE STENTS AND RELATED DEVICES, SYSTEMS, AND METHODS",,MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,,https://lens.org/080-052-097-282-661,Search Report,no,9,0,4,4,0,A61F2210/0076;;A61F2/848;;A61F2/915;;A61F2/966;;A61F2002/91558;;A61F2002/9665;;A61F2002/043;;A61F2250/0018;;A61F2250/0019;;A61F2250/0029;;A61F2/962;;A61F2/04;;A61F2002/043;;A61F2/90;;A61F2/962;;A61F2/848;;A61F2/966;;A61F2002/91558;;A61F2210/0076;;A61F2/915;;A61F2002/9665,A61F2/89;;A61F2/844;;A61F2/915;;A61F2/962;;A61F2/966;;A61L31/10,,0,0,,,,PENDING
3,US,A1,US 2018/0303594 A1,128-377-358-239-676,2018-10-25,2018,US 201815955895 A,2018-04-18,US 201815955895 A;;US 201762488405 P,2017-04-21,"DEPLOYABLE STENTS AND RELATED DEVICES, SYSTEMS, AND METHODS","Stents may be deployed within a patient, such as in a lung of a patient, by inserting a stent deployment device through a channel (such as a channel of a bronchoscope) and then deploying the stent via manipulation of the stent deployment device. The stents may include one or more features that facilitate or enable positioning of the stent at a location that is distal of the right bronchus or the left bronchus. Related devices, systems, and methods are also disclosed.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2017-05-08),https://lens.org/128-377-358-239-676,Patent Application,yes,0,8,4,4,0,A61F2/04;;A61F2/962;;A61F2/848;;A61F2/848;;A61F2/90;;A61F2/915;;A61F2/915;;A61F2/962;;A61F2/966;;A61F2/966;;A61F2002/043;;A61F2002/043;;A61F2002/91558;;A61F2002/91558;;A61F2002/9665;;A61F2002/9665;;A61F2210/0076;;A61F2210/0076;;A61F2250/0018;;A61F2250/0019;;A61F2250/0029,A61F2/04;;A61F2/90;;A61F2/962,,0,0,,,,PENDING
4,WO,A1,WO 2018/170064 A1,163-072-930-223-563,2018-09-20,2018,US 2018/0022340 W,2018-03-14,US 201762471746 P,2017-03-15,TRANSLUMINAL STENTS AND RELATED METHODS,"Transluminal stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,,https://lens.org/163-072-930-223-563,Patent Application,yes,3,0,8,8,0,D04C3/48;;A61F2250/0017;;A61F2250/0023;;D10B2401/046;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;D10B2403/0333;;D10B2101/20;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;A61F2250/0023;;A61F2250/0017;;D04C3/48;;D10B2401/046,A61F2/90;;A61F2/848;;A61F2/915,,5,4,006-789-378-752-706;;004-752-872-598-386;;047-509-240-293-146;;003-961-904-321-782,10.1016/j.gii.2015.03.003;;pmc4113054;;25071899;;10.5009/gnl.2014.8.4.341;;10.1016/j.acvd.2016.01.007;;26993360;;10.1111/den.12056;;23551382,"WEILERT, F. ET AL.: ""Specially designed stents for translumenal drainage"", GASTROINTESTINAL INTERVENTION, vol. 4, no. 1, June 2015 (2015-06-01), pages 40 - 45, XP055554091;;KAWAKAMI, H. ET AL.: ""Endoscopic ultrasound-guided transluminal drainage for peripancreatic fluid collections: where are we now?"", GUT AND LIVER, vol. 8, no. 4, 2014, pages 341 - 355, XP055554094;;SIZAROV, A. ET AL.: ""Novel materials and devices in the transcatheter creation of vascular anastomosis - the future comes slowly (part 2"", ARCHIVES OF CARDIOVASCULAR DISEASES, vol. 109, no. 4, 2016, pages 286 - 295, XP029501396;;CHEON, Y. K. ET AL.: ""Clinical feasibility of a new through-the-scope fully covered esophageal self-expandable metallic stent: an in vivo animal study"", DIGESTIVE ENDOSCOPY, vol. 26, no. 1, 2014, pages 32 - 36, XP055554099;;See also references of EP 3595594A4",PENDING
5,US,A1,US 2020/0375768 A1,000-388-269-370-105,2020-12-03,2020,US 202016994260 A,2020-08-14,US 202016994260 A;;US 201815921172 A;;US 201762471746 P,2017-03-15,TRANSLUMINAL STENTS AND RELATED METHODS,"Stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2017-03-27),https://lens.org/000-388-269-370-105,Patent Application,yes,0,2,8,8,0,D04C3/48;;A61F2250/0017;;A61F2250/0023;;D10B2401/046;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;D10B2403/0333;;D10B2101/20;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;A61F2250/0023;;A61F2250/0017;;D04C3/48;;D10B2401/046,A61F2/90;;D04C1/02;;D04C1/06;;D04C3/48,,0,0,,,,ACTIVE
6,US,A1,US 2018/0263797 A1,153-455-874-808-14X,2018-09-20,2018,US 201815921172 A,2018-03-14,US 201815921172 A;;US 201762471746 P,2017-03-15,TRANSLUMINAL STENTS AND RELATED METHODS,"Transluminal stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2017-03-27),https://lens.org/153-455-874-808-14X,Patent Application,yes,0,8,8,8,0,D04C3/48;;A61F2250/0017;;A61F2250/0023;;D10B2401/046;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;D10B2403/0333;;D10B2101/20;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;A61F2250/0023;;A61F2250/0017;;D04C3/48;;D10B2401/046,A61F2/90;;D04C1/02;;D04C1/06,,0,0,,,,ACTIVE
7,EP,A4,EP 3595594 A4,140-904-322-232-559,2021-04-21,2021,EP 18768455 A,2018-03-14,US 201762471746 P;;US 2018/0022340 W,2017-03-15,TRANSLUMINAL STENTS AND RELATED METHODS,,MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,,https://lens.org/140-904-322-232-559,Search Report,no,2,0,8,8,0,D04C3/48;;A61F2250/0017;;A61F2250/0023;;D10B2401/046;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;D10B2403/0333;;D10B2101/20;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;A61F2250/0023;;A61F2250/0017;;D04C3/48;;D10B2401/046,A61F2/90;;A61F2/848;;A61F2/915,,2,1,006-789-378-752-706,10.1016/j.gii.2015.03.003,"FRANK WEILERT ET AL: ""Specially designed stents for translumenal drainage"", GASTROINTESTINAL INTERVENTION, vol. 4, no. 1, 1 June 2015 (2015-06-01), pages 40 - 45, XP055554091, ISSN: 2213-1795, DOI: 10.1016/j.gii.2015.03.003;;See also references of WO 2018170064A1",PENDING
8,US,A1,US 2023/0381000 A1,181-008-443-362-095,2023-11-30,2023,US 202318327410 A,2023-06-01,US 202318327410 A;;US 202016994260 A;;US 201815921172 A;;US 201762471746 P,2017-03-15,STENTS AND RELATED METHODS,"Stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2017-03-27),https://lens.org/181-008-443-362-095,Patent Application,yes,0,0,8,8,0,D04C3/48;;A61F2250/0017;;A61F2250/0023;;D10B2401/046;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;D10B2403/0333;;D10B2101/20;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;A61F2250/0023;;A61F2250/0017;;D04C3/48;;D10B2401/046,A61F2/90;;D04C1/02;;D04C1/06;;D04C3/48,,0,0,,,,PENDING
9,US,B2,US 10744009 B2,112-917-060-857-336,2020-08-18,2020,US 201815921172 A,2018-03-14,US 201815921172 A;;US 201762471746 P,2017-03-15,Transluminal stents and related methods,"Transluminal stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2017-03-27),https://lens.org/112-917-060-857-336,Granted Patent,yes,196,0,8,8,0,D04C3/48;;A61F2250/0017;;A61F2250/0023;;D10B2401/046;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;D10B2403/0333;;D10B2101/20;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;A61F2250/0023;;A61F2250/0017;;D04C3/48;;D10B2401/046,A61F2/90;;D04C1/02;;D04C1/06;;D04C3/48,,59,4,004-752-872-598-386;;047-509-240-293-146;;006-789-378-752-706;;003-961-904-321-782,pmc4113054;;25071899;;10.5009/gnl.2014.8.4.341;;10.1016/j.acvd.2016.01.007;;26993360;;10.1016/j.gii.2015.03.003;;10.1111/den.12056;;23551382,"European Search Reported Sep. 24, 2018 for EP16759580.;;Notice of Allowance dated Sep. 6, 2018 for U.S. Appl. No. 29/597,873.;;Office Action dated Sep. 19, 2018 for U.S. Appl. No. 15/061,107.;;European Examination Report dated Feb. 18, 2015 for EP09791142.4.;;European Search Report dated Feb. 3, 2015 for EP12846255.3.;;European Search Report dated May 4, 2007 for EP05705271.4.;;European Search Report dated Jun. 30, 2017 for EP11846358.7.;;International Preliminary Report dated May 15, 2014 for PCT/US2012/062603.;;International Publication and Search Report dated Jun. 14, 2012 for WO2012078794.;;International Publication and Search Report dated Feb. 25, 2012 for WO2010021836.;;International Publication and Search Report dated Aug. 4, 2005 for WO2005070095.;;International Search Report and Written Opinion dated Jan. 9, 2018 for PCT/US2017/054000.;;International Search Report and Written Opinion dated Mar. 16, 2012 for PCT/US2011/063799.;;International Search Report and Written Opinion dated Mar. 29, 2013 for PCT/US2012/062603.;;International Search Report and Written Opinion dated Jun. 22, 2016 for PCT/US2016/020900.;;International Search Report and Written Opinion dated Sep. 28, 2005 for PCT/US2005/000515.;;International Search Report and Written Opinion dated Oct. 29, 2009 for PCT/US2009/052691.;;International Search Report and Written Opinion dated Nov. 23, 2006 for PCT/US2006/018811.;;Notice of Allowance dated Jan. 14, 2015 for U.S. Appl. No. 11/432,964.;;Notice of Allowance dated Mar. 6, 2013 for U.S. Appl. No. 12/535,980.;;Notice of Allowance dated Jun. 11, 2013 for U.S. Appl. No. 10/585,430.;;Notice of Allowance dated Jun. 22, 2016 for U.S. Appl. No. 13/664,267.;;Notice of Allowance dated Aug. 12, 2015 for U.S. Appl. No. 13/664,200.;;Notice of Allowance dated Sep. 23, 2016 for U.S. Appl. No. 13/664,234.;;Notice of Allowance dated Oct. 21, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated Jan. 3, 2014 for U.S. Appl. No. 11/432,964.;;Office Action dated Jan. 22, 2013 for U.S. Appl. No. 10/585,430.;;Office Action dated Jan. 31, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Mar. 16, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 22, 2016 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 24, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Apr. 6, 2016 for U.S. Appl. No. 13/664,137.;;Office Action dated May 5, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated May 25, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated Jun. 7, 2011 for U.S. Appl. No. 10/585,430.;;Office Action dated Jul. 9, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Jul. 25, 2013 for U.S. Appl. No. 11/432,964.;;Office Action dated Aug. 13, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Oct. 7, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Oct. 16, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Oct. 16, 2017 for U.S. Appl. No. 15/061,107.;;Office Action dated Nov. 9, 2010 for U.S. Appl. No. 10/585,430.;;Office Action dated Nov. 14, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated Nov. 19, 2015 for U.S. Appl. No. 13/664,137.;;Office Action dated Nov. 30, 2016 for U.S. Appl. No. 13/664,137.;;International Search Report and Written Opinion dated Jun. 29, 2018 for PCT/US2018/022340.;;International Search Report and Written Opinion dated Jun. 29, 2018 for PCT/US2018/022344.;;Office Action dated Apr. 25, 2018 for U.S. Appl. No. 15/061,107.;;Kawakami, et al.,Endoscopic Ultrasound-Guided Transluminal Drainage for Peripancreatic Fluid Collections: Where are we now?, Gut and Liver, vol. 8 No. 4 ,2014 ,341-355.;;Sizarov, et al.,Novel materials and Devices in the Transcatheter Creation of vascular Anastomosis—The Future Comes Slowly (Part 2), Archives of Cardiovascular Diseases, vol. 109 No. 4 ,2016 ,286-295.;;Weilert, et al.,Specially Designed Stents for Translumenal Drainage, Gastrointestinal Intervention, vol. 4 No. 1 ,2015 ,40-45.;;Office Action dated Dec. 2, 2019 for U.S. Appl. No. 15/718,419.;;Cheon, et al.,Clinical Feasibility of a New Through-The-Scope Fully Covered Esophageal Self-Expandable Metallic Stent: An In Vivo Animal Study, Digestive Endoscopy, vol. 26 No. 1 ,2014 ,32-36.;;Notice of Allowance dated Feb. 25, 2019 for U.S. Appl. No. 15/061,107.;;Office Action dated Dec. 7, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Dec. 8, 2009 for U.S. Appl. No. 10/585,430.;;Supplementary European Search Report dated May 4, 2007 for EP05705271.4.;;Sen, et al.,Laplace's Equation for Convective Scalar Transport in Potential Flow, Proc. R. Soc. Lond. A 456, pp. 3041-3045 ,2000.;;European Search Report dated Apr. 24, 2020 for EP17857414.1.",ACTIVE
10,US,B2,US 11707370 B2,088-645-005-351-311,2023-07-25,2023,US 202016994260 A,2020-08-14,US 202016994260 A;;US 201815921172 A;;US 201762471746 P,2017-03-15,Stents and related methods,"Stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2017-03-27),https://lens.org/088-645-005-351-311,Granted Patent,yes,323,0,8,8,0,D04C3/48;;A61F2250/0017;;A61F2250/0023;;D10B2401/046;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;D10B2403/0333;;D10B2101/20;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;A61F2250/0023;;A61F2250/0017;;D04C3/48;;D10B2401/046,A61F2/90;;D04C1/02;;D04C1/06;;D04C3/48,,84,4,003-961-904-321-782;;004-752-872-598-386;;047-509-240-293-146;;006-789-378-752-706,10.1111/den.12056;;23551382;;pmc4113054;;25071899;;10.5009/gnl.2014.8.4.341;;10.1016/j.acvd.2016.01.007;;26993360;;10.1016/j.gii.2015.03.003,"European Examination Report dated Apr. 26, 2021 for EP11846358.7.;;European Search Report dated Mar. 19, 2021 for EP18768455.0.;;Office Action dated May 21, 2021 for U.S. Appl. No. 15/921,220.;;European Search Report dated Nov. 9, 2020 for EP18767753.9.;;European Search Report dated Dec. 15, 2020 for EP18768455.0.;;Office Action dated Dec. 22, 2020 for U.S. Appl. No. 15/921,220.;;European Examination Report dated Feb. 18, 2015 for EP09791142.4.;;European Search Report dated Apr. 24, 2020 for EP17857414.1.;;European Search dated Sep. 24, 2018 for EP 16759580.;;International Preliminary Report dated May 15, 2014 for PCT/US2012/062603.;;International Publication and Search Report dated Jun. 14, 2012 for WO2012078794.;;International Publication and Search Report dated Feb. 25, 2012 for WO2010021836.;;International Publication and Search Report dated Aug. 4, 2005 for WO2005070095.;;International Search Report and Written Opinion dated Jan. 9, 2018 for PCT/US2017/054000.;;International Search Report and Written Opinion dated Mar. 16, 2012 for PCT/US2011/063799.;;International Search Report and Written Opinion dated Mar. 29, 2013 for PCT/US2012/062603.;;International Search Report and Written Opinion dated Jun. 22, 2016 for PCT/US2016/020900.;;International Search Report and Written Opinion dated Jun. 29, 2018 for PCT/US2018/022340.;;International Search Report and Written Opinion dated Jun. 29, 2018 for PCT/US2018/022344.;;International Search Report and Written Opinion dated Aug. 2, 2018 for PCT/US2018/028107.;;International Search Report and Written Opinion dated Sep. 28, 2005 for PCT/US2005/000515.;;International Search Report and Written Opinion dated Oct. 29, 2009 for PCT/US2009/052691.;;International Search Report and Written Opinion dated Nov. 23, 2006 for PCT/US2006/018811.;;Notice of Allowance dated Jan. 14, 2015 for U.S. Appl. No. 11/432,964.;;Notice of Allowance dated Feb. 25, 2019 for U.S. Appl. No. 15/061,107.;;Notice of Allowance dated Mar. 6, 2013 for U.S. Appl. No. 12/535,980.;;Notice of Allowance dated Jun. 11, 2013 for U.S. Appl. No. 10/585,430.;;Notice of Allowance dated Aug. 12, 2015 for U.S. Appl. No. 13/664,200.;;Notice of Allowance dated Sep. 6, 2018 for U.S. Appl. No. 29/597,873.;;Notice of Allowance dated Sep. 11, 2019 for U.S. Appl. No. 15/263,741.;;Notice of Allowance dated Sep. 23, 2016 for U.S. Appl. No. 13/664,234.;;Notice of Allowance dated Oct. 21, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated Jan. 3, 2014 for U.S. Appl. No. 11/432,964.;;Office Action dated Jan. 22, 2013 for U.S. Appl. No. 10/585,430.;;Office Action dated Jan. 31, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Feb. 5, 2020 for U.S. Appl. No. 15/921,172.;;Office Action dated Mar. 6, 2020 for U.S. Appl. No. 15/955,895.;;Office Action dated Mar. 16, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 22, 2016 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 24, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Apr. 6, 2016 for U.S. Appl. No. 13/664,137.;;Office Action dated Apr. 7, 2020 for U.S. Appl. No. 15/955,895.;;Office Action dated Apr. 25, 2018 for U.S. Appl. No. 15/061,107.;;Office Action dated May 5, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated May 25, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated May 30, 2019 for U.S. Appl. No. 15/263,741.;;Office Action dated Jun. 7, 2011 for U.S. Appl. No. 10/585,430.;;Office Action dated Jul. 9, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Jul. 25, 2013 for U.S. Appl. No. 11/432,964.;;Office Action dated Aug. 13, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Sep. 19, 2018 for U.S. Appl. No. 15/061,107.;;Office Action dated Oct. 7, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Oct. 16, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Oct. 16, 2017 for U.S. Appl. No. 15/061,107.;;Office Action dated Nov. 9, 2010 for U.S. Appl. No. 10/585,430.;;Office Action dated Nov. 14, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated Nov. 14, 2018 for U.S. Appl. No. 15/263,741.;;Office Action dated Nov. 19, 2015 for U.S. Appl. No. 13/664,137.;;Office Action dated Nov. 30, 2016 for U.S. Appl. No. 13/664,137.;;Office Action dated Dec. 7, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Dec. 8, 2009 for U.S. Appl. No. 10/585,430.;;Cheon, et al., Clinical Feasibility of a New Through-the-Scope Fully Covered Esophageal Self-Expandable Metallic Stent: an in Vivo Animal Study, Digestive Endoscopy, vol. 26 No. 1 ,2014 ,32-36.;;Kawakami, et al., Endoscopic Ultrasound-Guided Transluminal Drainage for Peripancreatic Fluid Collections: Where are we now?, Gut and Liver, vol. 8 No. 4 ,2014 ,341-355.;;Sen, et al., Laplace's Equation for Convective Scalar Transport in Potential Flow, Proc. R. Soc. Lond. A 456, pp. 3041-3045 ,2000.;;Sizarov, et al., Novel materials and Devices in the Transcatheter Creation of vascular Anastomosis—The Future Domes Slowly (Part 2), Archives of Cardiovascular Diseases, vol. 109 No. 4 ,2016 ,286-295.;;Weilert, et al., Specially Designed Stents forTranslumenal Drainage, Gastrointestinal Intervention, vol. 4 No. 1 ,2015 ,40-45.;;European Examination Report dated Feb. 2, 2023 for EP 18768455.0.;;Notice of Allowance dated Jan. 5, 2023 for U.S. Appl. No. 15/921,220.;;European Search Report dated Feb. 3, 2015 for EP12846255.3.;;European Search Report dated Apr. 9, 2018 for EP15860892.7.;;European Search Report dated May 4, 2007 for EP05705271.4.;;European Search Report dated Jun. 30, 2017 for EP11846358.7.;;International Publication and Search Report dated Dec. 19, 2006 for W02005070095.;;Office Action dated Dec. 2, 2019 for U.S. Appl. No. 15/718,419.;;International Search Report and Written Opinion dated Feb. 14, 2022 for PCT/US2021/056495.;;International Search Report and Written Opinion dated May 10, 2013 for PCT/US2012/060364.;;International Search Report and Written Opinion dated Sep. 12, 2016 for PCT/US2016/040174.;;International Search Report and Written Opinion dated Nov. 9, 2021 for PCT/US2021/042833.;;Notice of Allowance dated Jul. 22, 2020 for U.S. Appl. No. 15/718,419.;;Office Action dated Apr. 15, 2022 for U.S. Appl. No. 15/921,220.;;Office Action dated Apr. 23, 2020 for U.S. Appl. No. 15/596,823.;;Office Action dated Jun. 23, 2020 for U.S. Appl. No. 15/696,440.;;Office Action dated Oct. 16, 2019 for U.S. Appl. No. 15/596,823.;;Office Action dated Nov. 9, 2021 for U.S. Appl. No. 15/921,221.",ACTIVE
11,EP,A1,EP 3612140 A1,133-076-004-493-783,2020-02-26,2020,EP 18787294 A,2018-04-18,US 201762488405 P;;US 2018/0028107 W,2017-04-21,"DEPLOYABLE STENTS AND RELATED DEVICES, SYSTEMS, AND METHODS",,MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,,https://lens.org/133-076-004-493-783,Patent Application,yes,0,0,4,4,0,A61F2/04;;A61F2/962;;A61F2/848;;A61F2/848;;A61F2/90;;A61F2/915;;A61F2/915;;A61F2/962;;A61F2/966;;A61F2/966;;A61F2002/043;;A61F2002/043;;A61F2002/91558;;A61F2002/91558;;A61F2002/9665;;A61F2002/9665;;A61F2210/0076;;A61F2210/0076;;A61F2250/0018;;A61F2250/0019;;A61F2250/0029,A61F2/89;;A61F2/844;;A61F2/962;;A61L31/10,,0,0,,,,PENDING
12,WO,A1,WO 2018/195160 A1,011-173-150-228-807,2018-10-25,2018,US 2018/0028107 W,2018-04-18,US 201762488405 P,2017-04-21,"DEPLOYABLE STENTS AND RELATED DEVICES, SYSTEMS, AND METHODS","Stents may be deployed within a patient, such as in a lung of a patient, by inserting a stent deployment device through a channel (such as a channel of a bronchoscope) and then deploying the stent via manipulation of the stent deployment device. The stents may include one or more features that facilitate or enable positioning of the stent at a location that is distal of the right bronchus or the left bronchus. Related devices, systems, and methods are also disclosed.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,,https://lens.org/011-173-150-228-807,Patent Application,yes,11,0,4,4,0,A61F2210/0076;;A61F2/848;;A61F2/915;;A61F2/966;;A61F2002/91558;;A61F2002/9665;;A61F2002/043;;A61F2250/0018;;A61F2250/0019;;A61F2250/0029;;A61F2/962;;A61F2/04;;A61F2002/043;;A61F2/90;;A61F2/962;;A61F2/848;;A61F2/966;;A61F2002/91558;;A61F2210/0076;;A61F2/915;;A61F2002/9665,A61F2/89;;A61F2/844;;A61F2/962;;A61L31/10,,1,0,,,See also references of EP 3612140A4,PENDING
13,EP,A1,EP 3595594 A1,061-822-259-408-36X,2020-01-22,2020,EP 18768455 A,2018-03-14,US 201762471746 P;;US 2018/0022340 W,2017-03-15,TRANSLUMINAL STENTS AND RELATED METHODS,,MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;ELWOOD BRYAN K,,https://lens.org/061-822-259-408-36X,Patent Application,yes,0,0,8,8,0,D04C3/48;;A61F2250/0017;;A61F2250/0023;;D10B2401/046;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;D10B2403/0333;;D10B2101/20;;A61F2/90;;D04C1/06;;D04C1/02;;A61F2210/0014;;D10B2509/06;;A61F2230/0078;;A61F2240/001;;A61F2250/0098;;A61F2230/001;;A61F2250/0023;;A61F2250/0017;;D04C3/48;;D10B2401/046,A61F2/90;;A61F2/848;;A61F2/915,,0,0,,,,PENDING
14,US,B2,US 7030236 B2,158-835-929-360-546,2006-04-18,2006,US 9352302 A,2002-03-11,US 9352302 A;;US 27424901 P,2001-03-09,"Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof","The invention relates to treatment of cancers and cancerous cells which over-express α folate receptor (FRα) compared to the normal cells of the same tissue. The invention is directed to antisense oligonucleotides which are complimentary to the coding region of FRα, as well as the pharmaceutical compositions made thereof, and the methods of using the same for treatment of cancers, e.g. cancers of ovary, cervix, uterus, and brain.",JHAVERI MONA SAVITRI;;ELWOOD PATRICK CLAY;;CHUNG KOONG-NAH,JHAVERI MONA SAVITRI;;ELWOOD PATRICK CLAY;;CHUNG KOONG-NAH,FOLIGO THERAPEUTICS INC (2006-04-17),https://lens.org/158-835-929-360-546,Granted Patent,yes,3,17,3,3,4,A61K38/00;;C12N15/1138;;C12N2310/111;;C12N2310/12;;C12N2310/121;;C12N2310/315;;C12N15/1138;;C12N2310/315;;C12N2310/121;;A61K38/00;;C12N2310/12;;C12N2310/111,A61K48/00;;A61K38/00;;C07H21/02;;C07H21/04;;C12N15/113,536/24.5;;536/24.1;;536/23.1;;514/44;;435/320.1,3,1,127-720-974-316-873,8810326;;10.1016/s0021-9258(19)78324-0,"Hansen et al., Teratology vol. 59(6):385, Jun. 1999.;;Jhaveri et al., Proceedings of the American Association for Cancer Research Annual Meeting, No. 41, p. 643, Mar. 2000.;;Xin-Lau et al The Journal of Biological Chemistry, vol. 271(41):25539-25547, 1996.",EXPIRED
15,US,A1,US 2006/0178331 A1,012-111-737-538-436,2006-08-10,2006,US 32844906 A,2006-01-10,US 32844906 A;;US 9352302 A;;US 27424901 P,2001-03-09,"Antisense oligonucleotides targeting folate receptor alpha, and the use thereof","The invention relates to treatment of cancers and cancerous cells which over-express α folate receptor (FRα) compared to the normal cells of the same tissue. The invention is directed to antisense oligonucleotides which are complimentary to the coding region of FRα, as well as the pharmaceutical compositions made thereof, and the methods of using the same for treatment of cancers, e.g. cancers of ovary, cervix, uterus, and brain.",JHAVERI MONA S;;ELWOOD PATRICK C;;CHUNG KOONG-NAH,JHAVERI MONA S;;ELWOOD PATRICK C;;CHUNG KOONG-NAH,,https://lens.org/012-111-737-538-436,Patent Application,yes,3,0,3,3,4,A61K38/00;;C12N15/1138;;C12N2310/111;;C12N2310/12;;C12N2310/121;;C12N2310/315;;C12N15/1138;;C12N2310/315;;C12N2310/121;;A61K38/00;;C12N2310/12;;C12N2310/111,A61K48/00;;A61K33/06;;A61K38/00;;C07H21/04;;C12N15/113,514/44;;536/23.1;;424/682,0,0,,,,DISCONTINUED
16,US,A1,US 2003/0050267 A1,004-906-875-888-687,2003-03-13,2003,US 9352302 A,2002-03-11,US 9352302 A;;US 27424901 P,2001-03-09,"Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof","
   The invention relates to treatment of cancers and cancerous cells which over-express folate receptor (FR) compared to the normal cells of the same tissue. The invention is directed to antisense oligonucleotides which are complimentary to the coding region of FR, as well as the pharmaceutical compositions made thereof, and the methods of using the same for treatment of cancers, e.g. cancers of ovary, cervix, uterus, and brain. 
",JHAVERI MONA SAVITRI;;ELWOOD PATRICK CLAY;;CHUNG KOONG-NAH,JHAVERI MONA SAVITRI;;ELWOOD PATRICK CLAY;;CHUNG KOONG-NAH,FOLIGO THERAPEUTICS INC (2006-04-17),https://lens.org/004-906-875-888-687,Patent Application,yes,3,2,3,3,0,A61K38/00;;C12N15/1138;;C12N2310/111;;C12N2310/12;;C12N2310/121;;C12N2310/315;;C12N15/1138;;C12N2310/315;;C12N2310/121;;A61K38/00;;C12N2310/12;;C12N2310/111,A61K38/00;;C12N15/113,514/44;;536/23.2,0,0,,,,EXPIRED
17,EP,A1,EP 3595596 A1,123-637-629-042-40X,2020-01-22,2020,EP 18767753 A,2018-03-14,US 201762471767 P;;US 2018/0022344 W,2017-03-15,TRANSLUMINAL DELIVERY DEVICES AND RELATED KITS AND METHODS,,MERIT MEDICAL SYSTEMS INC,ELWOOD BRYAN K;;ROBINSON THOMAS PATRICK;;ELLER ZEKE;;TWOMEY JOHN,,https://lens.org/123-637-629-042-40X,Patent Application,yes,0,0,7,7,0,A61F2/90;;A61F2230/001;;A61B2018/00601;;A61B17/32053;;A61B17/3468;;A61B2017/00278;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61B2018/00077;;A61B2018/00083;;A61B1/0014;;A61F2/9517;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/0034;;A61B2018/00982;;A61M25/0082;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61M25/09;;A61B2018/00077;;A61B2018/00083;;A61B17/320016;;A61B1/0014;;A61F2230/001;;A61F2/90;;A61B2018/00601;;A61B17/3468;;A61B2017/00278;;A61B17/32053;;A61F2/9517,A61F2/966;;A61B18/00;;A61B18/14;;A61M25/00;;A61M25/01,,0,0,,,,ACTIVE
18,US,A1,US 2023/0381003 A1,111-308-760-270-085,2023-11-30,2023,US 202318301717 A,2023-04-17,US 202318301717 A;;US 201815921220 A;;US 201762471767 P,2017-03-15,TRANSLUMINAL DELIVERY DEVICES AND RELATED KITS AND METHODS,"Prosthesis deployment devices are disclosed herein. In some embodiments, the prosthesis deployment device comprises an elongate delivery catheter assembly configured for electrosurgery and also configured to retain and deploy a prosthesis. Kits comprising the prosthesis deployment devices with a prosthesis loaded into a prosthesis pod of the device are disclosed herein as well as methods of using the prosthesis deployment devices.",MERIT MEDICAL SYSTEMS INC,ELWOOD BRYAN K;;ROBINSON THOMAS PATRICK;;ELLER ZEKE;;TWOMEY JOHN,MERIT MEDICAL SYSTEMS INC (2017-03-27),https://lens.org/111-308-760-270-085,Patent Application,yes,0,0,7,7,0,A61F2/90;;A61F2230/001;;A61B2018/00601;;A61B17/32053;;A61B17/3468;;A61B2017/00278;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61B2018/00077;;A61B2018/00083;;A61B1/0014;;A61F2/9517;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/0034;;A61B2018/00982;;A61M25/0082;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61M25/09;;A61B2018/00077;;A61B2018/00083;;A61B17/320016;;A61B1/0014;;A61F2230/001;;A61F2/90;;A61B2018/00601;;A61B17/3468;;A61B2017/00278;;A61B17/32053;;A61F2/9517,A61F2/95;;A61B1/00;;A61B1/018;;A61B8/12;;A61B17/00;;A61B17/32;;A61B17/3205;;A61B17/34;;A61B18/00;;A61B18/12;;A61B18/14;;A61F2/90;;A61M25/00;;A61M25/09,,0,0,,,,PENDING
19,US,B2,US 11892199 B2,083-691-443-265-179,2024-02-06,2024,US 202217729294 A,2022-04-26,US 202217729294 A;;US 202017102907 A;;US 201816105273 A,2018-08-20,Energy efficient water heater,"Systems and methods for controlling the output water temperature of a water heater are disclosed herein. The water heater preferably has a water inlet, heating unit, and water output. The system comprises a proportional flow restrictor placed near the water output and a controller which is configured to direct the heating unit to heat the water and the proportional flow restrictor to produce a flow rate of the output water. Temperature sensors may be used to control the proportional flow restrictor. The proportional flow restrictor can also be controlled based on the amount of heat energy applied to the heating unit.",RV MOBILE POWER LLC,NADAI KEVIN PATRICK;;ROSS KENT ELWOOD;;TRIBBLE II EDWARD LEROY,,https://lens.org/083-691-443-265-179,Granted Patent,yes,22,0,6,6,0,F24H1/125;;F24H9/2035;;G05D23/1931;;F24H9/2035;;F24H1/125;;F16K17/38;;F24H9/1836;;F24H9/139,F24H9/20;;F16K17/38;;F24H1/12;;F24H9/13;;F24H9/1836,,0,0,,,,ACTIVE
20,EP,A4,EP 3595596 A4,146-397-389-698-50X,2020-12-09,2020,EP 18767753 A,2018-03-14,US 201762471767 P;;US 2018/0022344 W,2017-03-15,TRANSLUMINAL DELIVERY DEVICES AND RELATED KITS AND METHODS,,MERIT MEDICAL SYSTEMS INC,ELWOOD BRYAN K;;ROBINSON THOMAS PATRICK;;ELLER ZEKE;;TWOMEY JOHN,,https://lens.org/146-397-389-698-50X,Search Report,no,2,0,7,7,0,A61F2/90;;A61F2230/001;;A61B2018/00601;;A61B17/32053;;A61B17/3468;;A61B2017/00278;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61B2018/00077;;A61B2018/00083;;A61B1/0014;;A61F2/9517;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/0034;;A61B2018/00982;;A61M25/0082;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61M25/09;;A61B2018/00077;;A61B2018/00083;;A61B17/320016;;A61B1/0014;;A61F2230/001;;A61F2/90;;A61B2018/00601;;A61B17/3468;;A61B2017/00278;;A61B17/32053;;A61F2/9517,A61F2/966;;A61B18/00;;A61B18/14;;A61M25/00;;A61M25/01,,1,0,,,See also references of WO 2018170066A1,ACTIVE
21,US,A1,US 2020/0056812 A1,082-904-392-624-839,2020-02-20,2020,US 201816105273 A,2018-08-20,US 201816105273 A,2018-08-20,Energy Efficient Water Heater,"Apparatuses of an energy efficient water heater and methods for controlling the same are disclosed. In one embodiment, a water heater may include a water inlet configured to receive input water, an input water temperature sensor configured to detect a temperature of the input water, a user interface unit configured to receive an output water temperature setting selected by a user, a controller configured to determine a flow rate of an output water based on the input water temperature and the output water temperature setting, a heating unit configured to heat the input water to produce the output water, the controller is further configured to control the heating unit and a proportional flow restrictor to produce the flow rate of the output water, and a water outlet configured to transfer the output water at the flow rate of the output water.",COVENANT PATENT HOLDING GROUP,NADAI KEVIN PATRICK;;ROSS KENT ELWOOD;;TRIBBLE II EDWARD LEROY,SANDBAR MANUFACTURING CORPORATION (2021-04-01);;COVENANT PATENT HOLDING GROUP (2020-11-17);;SANDBAR TECHNOLOGIES LLC (2021-10-21),https://lens.org/082-904-392-624-839,Patent Application,yes,10,2,6,6,0,F24H1/125;;F24H9/2035;;G05D23/1931;;F24H9/2035;;F24H1/125;;F16K17/38;;F24H9/1836;;F24H9/139,F24H9/20;;F16K17/38;;F24H1/12;;F24H9/12;;F24H9/18,,0,0,,,,ACTIVE
22,US,B2,US 11628078 B2,080-826-923-521-086,2023-04-18,2023,US 201815921220 A,2018-03-14,US 201815921220 A;;US 201762471767 P,2017-03-15,Transluminal delivery devices and related kits and methods,"Prosthesis deployment devices are disclosed herein. In some embodiments, the prosthesis deployment device comprises an elongate delivery catheter assembly configured for electrosurgery and also configured to retain and deploy a prosthesis. Kits comprising the prosthesis deployment devices with a prosthesis loaded into a prosthesis pod of the device are disclosed herein as well as methods of using the prosthesis deployment devices.",MERIT MEDICAL SYSTEMS INC,ELWOOD BRYAN K;;ROBINSON THOMAS PATRICK;;ELLER ZEKE;;TWOMEY JOHN,MERIT MEDICAL SYSTEMS INC (2017-03-27),https://lens.org/080-826-923-521-086,Granted Patent,yes,212,0,7,7,0,A61F2/90;;A61F2230/001;;A61B2018/00601;;A61B17/32053;;A61B17/3468;;A61B2017/00278;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61B2018/00077;;A61B2018/00083;;A61B1/0014;;A61F2/9517;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/0034;;A61B2018/00982;;A61M25/0082;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61M25/09;;A61B2018/00077;;A61B2018/00083;;A61B17/320016;;A61B1/0014;;A61F2230/001;;A61F2/90;;A61B2018/00601;;A61B17/3468;;A61B2017/00278;;A61B17/32053;;A61F2/9517,A61B17/00;;A61B1/00;;A61B1/018;;A61B8/12;;A61B17/32;;A61B17/3205;;A61B17/34;;A61B18/00;;A61B18/12;;A61B18/14;;A61F2/90;;A61F2/95;;A61M25/00;;A61M25/09,,65,4,004-752-872-598-386;;047-509-240-293-146;;006-789-378-752-706;;003-961-904-321-782,pmc4113054;;25071899;;10.5009/gnl.2014.8.4.341;;10.1016/j.acvd.2016.01.007;;26993360;;10.1016/j.gii.2015.03.003;;10.1111/den.12056;;23551382,"Office Action dated Dec. 2, 2019 for U.S. Appl. No. 15/718,419.;;Notice of Allowance dated Feb. 25, 2019 for U.S. Appl. No. 15/061,107.;;European Search Report dated Apr. 24, 2020 for EP17857414.1.;;European Examination Report dated Feb. 18, 2015 for EP09791142.4.;;European Search Report dated Feb. 3, 2015 for EP12846255.3.;;European Search Report dated Jun. 30, 2017 for EP11846358.7.;;International Preliminary Report dated May 15, 2014 for PCT/US2012/062603.;;International Publication and Search Report dated Jun. 14, 2012 for WO2012078794.;;International Publication and Search Report dated Feb. 25, 2012 for WO2010021836.;;International Publication and Search Report dated Aug. 4, 2005 for WO2005070095.;;International Search Report and Written Opinion dated Jan. 9, 2018 for PCT/US2017/054000.;;International Search Report and Written Opinion dated Mar. 16, 2012 for PCT/US2011/063799.;;International Search Report and Written Opinion dated Mar. 29, 2013 for PCT/US2012/062603.;;International Search Report and Written Opinion dated Jun. 22, 2016 for PCT/US2016/020900.;;International Search Report and Written Opinion dated Sep. 28, 2005 for PCT/US2005/000515.;;International Search Report and Written Opinion dated Oct. 29, 2009 for PCT/US2009/052691.;;International Search Report and Written Opinion dated Nov. 23, 2006 for PCT/US2006/018811.;;Notice of Allowance dated Jan. 14, 2015 for U.S. Appl. No. 11/432,964.;;Notice of Allowance dated Mar. 6, 2013 for U.S. Appl. No. 12/535,980.;;Notice of Allowance dated Jun. 11, 2013 for U.S. Appl. No. 10/585,430.;;Notice of Allowance dated Jun. 22, 2016 for U.S. Appl. No. 13/664,267.;;Notice of Allowance dated Aug. 12, 2015 for U.S. Appl. No. 13/664,200.;;Notice of Allowance dated Sep. 23, 2016 for U.S. Appl. No. 13/664,234.;;Notice of Allowance dated Oct. 21, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated Jan. 3, 2014 for U.S. Appl. No. 11/432,964.;;Office Action dated Jan. 22, 2013 for U.S. Appl. No. 10/585,430.;;Office Action dated Jan. 31, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Mar. 16, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 22, 2016 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 24, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Apr. 6, 2016 for U.S. Appl. No. 13/664,137.;;Office Action dated May 5, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated May 25, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated Jun. 7, 2011 for U.S. Appl. No. 10/585,430.;;Office Action dated Jul. 9, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Jul. 25, 2013 for U.S. Appl. No. 11/432,964.;;Office Action dated Aug. 13, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Oct. 7, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Oct. 16, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Oct. 16, 2017 for U.S. Appl. No. 15/061,107.;;Office Action dated Nov. 9, 2010 for U.S. Appl. No. 10/585,430.;;Office Action dated Nov. 14, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated Nov. 19, 2015 for U.S. Appl. No. 13/664,137.;;Office Action dated Nov. 30, 2016 for U.S. Appl. No. 13/664,137.;;Supplementary European Search Report dated May 4, 2007 for EP05705271.4.;;Office Action dated Feb. 5, 2020 for U.S. Appl. No. 15/921,172.;;International Search Report and Written Opinion dated Jun. 29, 2018 for PCT/US2018/022340.;;International Search Report and Written Opinion dated Jun. 29, 2018 for PCT/US2018/022344.;;Office Action dated Apr. 25, 2018 for U.S. Appl. No. 15/061,107.;;Kawakami, et al.,Endoscopic Ultrasound-Guided Transluminal Drainage for Peripancreatic Fluid Collections: Where are we now?, Gut and Liver, vol. 8 No. 4 ,2014 ,341-355.;;Sizarov et al.,Novel materials and Devices in the Transcatheter Creation of vascular Anastomosis—The Future Comes Slowly (Part 2), Archives of Cardiovascular Diseases, vol. 109 No. 4 ,2016 ,286-295.;;Weilert, et al.,Specially Designed Stents for Translumenal Drainage, Gastrointestinal Intervention, vol. 4 No. 1 ,2015 ,40-45.;;European Search Report dated May 4, 2007 for EP05705271.4.;;Office Action dated Dec. 7, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Dec. 8, 2009 for U.S. Appl. No. 10/585,430.;;Sen, et al.,Laplace's Equation for Convective Scalar Transport in Potential Flow, Proc. R. Soc. Lond. A 456, pp. 3041-3045 ,2000.;;Cheon, et al.,Clinical Feasibility of a New Through-The-Scope Fully Covered Esophageal Self-Expandable Metallic Stent: An In Vivo Animal Study, Digestive Endoscopy, vol. 26 No. 1 ,2014 ,32-36.;;European Search Reported dated Sep. 24, 2018 for EP 16759580.;;Notice of Allowance dated Sep. 6, 2018 for U.S. Appl. No. 29/597,873.;;Office Action dated Sep. 19, 2018 for U.S. Appl. No. 15/061,107.;;European Search Report dated Nov. 9, 2020 for EP18767753.9.;;Notice of Allowance dated Jul. 22, 2020 for U.S. Appl. No. 15/718,419.;;European Search Report dated Mar. 19, 2021 for EP18768455.0.;;European Search Report dated Dec. 15, 2020 for EP18768455.0.;;European Examination Report dated Apr. 26, 2021 for EP11846358.7.",ACTIVE
23,WO,A1,WO 2018/170066 A1,187-035-044-846-414,2018-09-20,2018,US 2018/0022344 W,2018-03-14,US 201762471767 P,2017-03-15,TRANSLUMINAL DELIVERY DEVICES AND RELATED KITS AND METHODS,"Prosthesis deployment devices are disclosed herein. In some embodiments, the prosthesis deployment device comprises an elongate delivery catheter assembly configured for electrosurgery and also configured to retain and deploy a prosthesis. Kits comprising the prosthesis deployment devices with a prosthesis loaded into a prosthesis pod of the device are disclosed herein as well as methods of using the prosthesis deployment devices.",MERIT MEDICAL SYSTEMS INC,ELWOOD BRYAN K;;ROBINSON THOMAS PATRICK;;ELLER ZEKE;;TWOMEY JOHN,,https://lens.org/187-035-044-846-414,Patent Application,yes,6,0,7,7,0,A61F2/90;;A61F2230/001;;A61B2018/00601;;A61B17/32053;;A61B17/3468;;A61B2017/00278;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61B2018/00077;;A61B2018/00083;;A61B1/0014;;A61F2/9517;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/0034;;A61B2018/00982;;A61M25/0082;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61M25/09;;A61B2018/00077;;A61B2018/00083;;A61B17/320016;;A61B1/0014;;A61F2230/001;;A61F2/90;;A61B2018/00601;;A61B17/3468;;A61B2017/00278;;A61B17/32053;;A61F2/9517,A61F2/966;;A61B18/00;;A61B18/14;;A61M25/00;;A61M25/01,,1,0,,,See also references of EP 3595596A4,PENDING
24,US,A1,US 2021/0080149 A1,071-325-962-111-424,2021-03-18,2021,US 202017102907 A,2020-11-24,US 202017102907 A;;US 201816105273 A,2018-08-20,Energy Efficient Water Heater,"Apparatuses of an energy efficient water heater and methods for controlling the same are disclosed. In one embodiment, a water heater may include a water inlet configured to receive input water, an input water temperature sensor configured to detect a temperature of the input water, a user interface unit configured to receive an output water temperature setting selected by a user, a controller configured to determine a flow rate of an output water based on the input water temperature and the output water temperature setting, a heating unit configured to heat the input water to produce the output water, the controller is further configured to control the heating unit and a proportional flow restrictor to produce the flow rate of the output water, and a water outlet configured to transfer the output water at the flow rate of the output water.",COVENANT PATENT HOLDING GROUP,NADAI KEVIN PATRICK;;ROSS KENT ELWOOD;;TRIBBLE II EDWARD LEROY,SANDBAR MANUFACTURING CORPORATION (2021-04-06);;COVENANT PATENT HOLDING GROUP (2020-11-17);;SANDBAR TECHNOLOGIES LLC (2021-10-21),https://lens.org/071-325-962-111-424,Patent Application,yes,0,0,6,6,0,F24H1/125;;F24H9/2035;;G05D23/1931;;F24H9/2035;;F24H1/125;;F16K17/38;;F24H9/1836;;F24H9/139,F24H9/20;;F16K17/38;;F24H1/12;;F24H9/12;;F24H9/18,,0,0,,,,ACTIVE
25,US,B2,US 11313590 B2,097-731-383-737-323,2022-04-26,2022,US 202017102907 A,2020-11-24,US 202017102907 A;;US 201816105273 A,2018-08-20,Energy efficient water heater,"Apparatuses of an energy efficient water heater and methods for controlling the same are disclosed. In one embodiment, a water heater may include a water inlet configured to receive input water, an input water temperature sensor configured to detect a temperature of the input water, a user interface unit configured to receive an output water temperature setting selected by a user, a controller configured to determine a flow rate of an output water based on the input water temperature and the output water temperature setting, a heating unit configured to heat the input water to produce the output water, the controller is further configured to control the heating unit and a proportional flow restrictor to produce the flow rate of the output water, and a water outlet configured to transfer the output water at the flow rate of the output water.",SANDBAR TECH LLC;;NADAI SHERRY,NADAI KEVIN PATRICK;;ROSS KENT ELWOOD;;TRIBBLE II EDWARD LEROY,SANDBAR MANUFACTURING CORPORATION (2021-04-06);;COVENANT PATENT HOLDING GROUP (2020-11-17);;SANDBAR TECHNOLOGIES LLC (2021-10-21),https://lens.org/097-731-383-737-323,Granted Patent,yes,14,0,6,6,0,F24H1/125;;F24H9/2035;;G05D23/1931;;F24H9/2035;;F24H1/125;;F16K17/38;;F24H9/1836;;F24H9/139,F24H9/20;;F16K17/38;;F24H1/12;;F24H9/12;;F24H9/1836,,0,0,,,,ACTIVE
26,US,A1,US 2018/0263799 A1,043-695-812-236-750,2018-09-20,2018,US 201815921220 A,2018-03-14,US 201815921220 A;;US 201762471767 P,2017-03-15,TRANSLUMINAL DELIVERY DEVICES AND RELATED KITS AND METHODS,"Prosthesis deployment devices are disclosed herein. In some embodiments, the prosthesis deployment device comprises an elongate delivery catheter assembly configured for electrosurgery and also configured to retain and deploy a prosthesis. Kits comprising the prosthesis deployment devices with a prosthesis loaded into a prosthesis pod of the device are disclosed herein as well as methods of using the prosthesis deployment devices.",MERIT MEDICAL SYSTEMS INC,ELWOOD BRYAN K;;ROBINSON THOMAS PATRICK;;ELLER ZEKE;;TWOMEY JOHN,MERIT MEDICAL SYSTEMS INC (2017-03-27),https://lens.org/043-695-812-236-750,Patent Application,yes,2,10,7,7,0,A61F2/90;;A61F2230/001;;A61B2018/00601;;A61B17/32053;;A61B17/3468;;A61B2017/00278;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61B2018/00077;;A61B2018/00083;;A61B1/0014;;A61F2/9517;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/0034;;A61B2018/00982;;A61M25/0082;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61M25/09;;A61B2018/00077;;A61B2018/00083;;A61B17/320016;;A61B1/0014;;A61F2230/001;;A61F2/90;;A61B2018/00601;;A61B17/3468;;A61B2017/00278;;A61B17/32053;;A61F2/9517,A61F2/95;;A61B1/00;;A61B1/018;;A61B8/12;;A61B18/14,,0,0,,,,ACTIVE
27,US,A1,US 2022/0252303 A1,086-885-678-020-912,2022-08-11,2022,US 202217729294 A,2022-04-26,US 202217729294 A;;US 202017102907 A;;US 201816105273 A,2018-08-20,Energy Efficient Water Heater,"Systems and methods for controlling the output water temperature of a water heater are disclosed herein. The water heater preferably has a water inlet, heating unit, and water output. The system comprises a proportional flow restrictor placed near the water output and a controller which is configured to direct the heating unit to heat the water and the proportional flow restrictor to produce a flow rate of the output water. Temperature sensors may be used to control the proportional flow restrictor. The proportional flow restrictor can also be controlled based on the amount of heat energy applied to the heating unit.",RV MOBILE POWER LLC,NADAI KEVIN PATRICK;;ROSS KENT ELWOOD;;TRIBBLE II EDWARD LEROY,,https://lens.org/086-885-678-020-912,Patent Application,yes,0,0,6,6,0,F24H1/125;;F24H9/2035;;G05D23/1931;;F24H9/2035;;F24H1/125;;F16K17/38;;F24H9/1836;;F24H9/139,F24H9/20;;F16K17/38;;F24H1/12;;F24H9/13;;F24H9/1836,,0,0,,,,ACTIVE
28,EP,B1,EP 3595596 B1,039-476-200-724-679,2023-09-06,2023,EP 18767753 A,2018-03-14,US 201762471767 P;;US 2018/0022344 W,2017-03-15,TRANSLUMINAL DELIVERY DEVICES AND RELATED KITS,,MERIT MEDICAL SYSTEMS INC,ELWOOD BRYAN K;;ROBINSON THOMAS PATRICK;;ELLER ZEKE;;TWOMEY JOHN,,https://lens.org/039-476-200-724-679,Granted Patent,yes,1,0,7,7,0,A61F2/90;;A61F2230/001;;A61B2018/00601;;A61B17/32053;;A61B17/3468;;A61B2017/00278;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61B2018/00077;;A61B2018/00083;;A61B1/0014;;A61F2/9517;;A61F2/95;;A61B1/018;;A61B8/12;;A61B18/1492;;A61B2017/0034;;A61B2018/00982;;A61M25/0082;;A61B2017/00424;;A61B2018/126;;A61B2018/00178;;A61M25/09;;A61B2018/00077;;A61B2018/00083;;A61B17/320016;;A61B1/0014;;A61F2230/001;;A61F2/90;;A61B2018/00601;;A61B17/3468;;A61B2017/00278;;A61B17/32053;;A61F2/9517,A61F2/966;;A61B18/00;;A61B18/14;;A61M25/00;;A61M25/01,,0,0,,,,ACTIVE
29,US,B2,US 10876767 B2,099-103-936-786-965,2020-12-29,2020,US 201816105273 A,2018-08-20,US 201816105273 A,2018-08-20,Energy efficient water heater,"Apparatuses of an energy efficient water heater and methods for controlling the same are disclosed. In one embodiment, a water heater may include a water inlet configured to receive input water, an input water temperature sensor configured to detect a temperature of the input water, a user interface unit configured to receive an output water temperature setting selected by a user, a controller configured to determine a flow rate of an output water based on the input water temperature and the output water temperature setting, a heating unit configured to heat the input water to produce the output water, the controller is further configured to control the heating unit and a proportional flow restrictor to produce the flow rate of the output water, and a water outlet configured to transfer the output water at the flow rate of the output water.",COVENANT PATENT HOLDING GROUP,NADAI KEVIN PATRICK;;ROSS KENT ELWOOD;;TRIBBLE II EDWARD LEROY,SANDBAR MANUFACTURING CORPORATION (2021-04-01);;COVENANT PATENT HOLDING GROUP (2020-11-17);;SANDBAR TECHNOLOGIES LLC (2021-10-21),https://lens.org/099-103-936-786-965,Granted Patent,yes,10,0,6,6,0,F24H1/125;;F24H9/2035;;G05D23/1931;;F24H9/2035;;F24H1/125;;F16K17/38;;F24H9/1836;;F24H9/139,F24H9/00;;F16K17/38;;F24H1/12;;F24H9/12;;F24H9/18;;F24H9/20,,0,0,,,,ACTIVE
30,US,A1,US 2017/0071772 A1,137-890-682-899-629,2017-03-16,2017,US 201615263741 A,2016-09-13,US 201615263741 A;;US 201562218892 P,2015-09-15,IMPLANTABLE DEVICE DELIVERY SYSTEM,"Delivery systems and methods for deploying an implantable device are disclosed, which can include a delivery device having an outer tubular member and an inner assembly. The inner assembly is disposed within and is slidably movable relative to the outer tubular member. The inner assembly can include a pusher at a distal portion. The pusher abuts and restricts proximal movement, relative to the inner assembly, of a crimped implantable device within the outer tubular member. The pusher can include a slot to accommodate a suture binding mechanism of the implantable device. The delivery device can include a tip disposed at a distal end. The tip includes a tip transition zone. The inner sheath and outer tubular member can each have sections of distinct rigidity along their lengths with transition zones between the sections. A transition zone of the outer tubular member and a transition zone of the inner sheath can be longitudinally offset.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;GILL BARTON;;GILL DARLA;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2015-09-30),https://lens.org/137-890-682-899-629,Patent Application,yes,17,1,4,4,0,A61F2/966;;A61F2/915;;A61F2002/9665;;A61F2/966;;A61F2/915;;A61F2002/9665,A61F2/966;;A61F2/915,,0,0,,,,ACTIVE
31,US,B2,US 11304837 B2,035-908-334-424-015,2022-04-19,2022,US 201916679680 A,2019-11-11,US 201916679680 A;;US 201615263741 A;;US 201562218892 P,2015-09-15,Implantable device delivery system,"Delivery systems and methods for deploying an implantable device are disclosed, which can include a delivery device having an outer tubular member and an inner assembly. The inner assembly is disposed within and is slidably movable relative to the outer tubular member. The inner assembly can include a pusher at a distal portion. The pusher abuts and restricts proximal movement, relative to the inner assembly, of a crimped implantable device within the outer tubular member. The pusher can include a slot to accommodate a suture binding mechanism of the implantable device. The delivery device can include a tip disposed at a distal end. The tip includes a tip transition zone. The inner sheath and outer tubular member can each have sections of distinct rigidity along their lengths with transition zones between the sections. A transition zone of the outer tubular member and a transition zone of the inner sheath can be longitudinally offset.",MERIT MEDICAL SYSTEM INC;;MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;GILL BARTON;;GILL DARLA;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2015-09-30),https://lens.org/035-908-334-424-015,Granted Patent,yes,199,0,4,4,0,A61F2/966;;A61F2/915;;A61F2002/9665;;A61F2/966;;A61F2/915;;A61F2002/9665,A61F2/966;;A61F2/915,,52,0,,,"Office Action dated Jan. 22, 2013 for U.S. Appl. No. 10/585,430.;;Office Action dated Jan. 31, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Mar. 16, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 22, 2016 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 24, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Apr. 6, 2016 for U.S. Appl. No. 13/664,137.;;Office Action dated Apr. 25, 2018 for U.S. Appl. No. 15/061,107.;;Office Action dated May 5, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated May 25, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated May 30, 2019 for U.S. Appl. No. 15/263,741.;;Office Action dated Jun. 7, 2011 for U.S. Appl. No. 10/585,430.;;Office Action dated Jul. 9, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Jul. 25, 2013 for U.S. Appl. No. 11/432,964.;;Office Action dated Aug. 13, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Sep. 19, 2018 for U.S. Appl. No. 15/061,107.;;Office Action dated Oct. 7, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Oct. 16, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Oct. 16, 2017 for U.S. Appl. No. 15/061,107.;;Office Action dated Nov. 9, 2010 for U.S. Appl. No. 10/585,430.;;Office Action dated Nov. 14, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated Nov. 14, 2018 for U.S. Appl. No. 15/263,741.;;Office Action dated Nov. 19, 2015 for U.S. Appl. No. 13/664,137.;;Office Action dated Nov. 30, 2016 for U.S. Appl. No. 13/664,137.;;Office Action dated Dec. 7, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Dec. 8, 2009 for U.S. Appl. No. 10/585,430.;;Sen, et al.,Laplace's Equation for Convective Scalar Transport in Potential Flow, Proc. R. Soc. Lond. A 456, pp. 3041-3045 ,2000.;;European Examination Report dated Feb. 18, 2015 for EP09791142.4.;;International Preliminary Report dated May 15, 2014 for PCT/US2012/062603.;;International Publication and Search Report dated Jun. 14, 2012 for WO2012078794.;;International Publication and Search Report dated Feb. 25, 2012 for WO2010021836.;;International Publication and Search Report dated Aug. 4, 2005 for WO2005070095.;;International Search Report and Written Opinion dated Jan. 9, 2018 for PCT/US2017/054000.;;International Search Report and Written Opinion dated Mar. 16, 2012 for PCT/US2011/063799.;;International Search Report and Written Opinion dated Mar. 29, 2013 for PCT/US2012/062603.;;International Search Report and Written Opinion dated Jun. 22, 2016 for PCT/US2016/020900.;;International Search Report and Written Opinion dated Jun. 29, 2018 for PCT/US2018/022344.;;International Search Report and Written Opinion dated Aug. 2, 2018 for PCT/US2018/028107.;;International Search Report and Written Opinion dated Sep. 28, 2005 for PCT/US2005/000515.;;International Search Report and Written Opinion dated Oct. 29, 2009 for PCT/US2009/052691.;;International Search Report and Written Opinion dated Nov. 23, 2006 for PCT/US2006/018811.;;Notice of Allowance dated Jan. 14, 2015 for U.S. Appl. No. 11/432,964.;;Notice of Allowance dated Feb. 25, 2019 for U.S. Appl. No. 15/061,107.;;Notice of Allowance dated Mar. 6, 2013 for U.S. Appl. No. 12/535,980.;;Notice of Allowance dated Jun. 11, 2013 for U.S. Appl. No. 10/585,430.;;Notice of Allowance dated Jun. 22, 2016 for U.S. Appl. No. 13/664,267.;;Notice of Allowance dated Aug. 12, 2015 for U.S. Appl. No. 13/664,200.;;Notice of Allowance dated Sep. 6, 2018 for U.S. Appl. No. 29/597,873.;;Notice of Allowance dated Sep. 11, 2019 for U.S. Appl. No. 15/263,741.;;Notice of Allowance dated Sep. 23, 2016 for U.S. Appl. No. 13/664,234.;;Notice of Allowance dated Oct. 21, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated Jan. 3, 2014 for U.S. Appl. No. 11/432,964.;;European Examination Report dated Apr. 26, 2021 for EP11846358.7.",ACTIVE
32,US,B2,US 10470906 B2,082-490-805-287-301,2019-11-12,2019,US 201615263741 A,2016-09-13,US 201615263741 A;;US 201562218892 P,2015-09-15,Implantable device delivery system,"Delivery systems and methods for deploying an implantable device are disclosed, which can include a delivery device having an outer tubular member and an inner assembly. The inner assembly is disposed within and is slidably movable relative to the outer tubular member. The inner assembly can include a pusher at a distal portion. The pusher abuts and restricts proximal movement, relative to the inner assembly, of a crimped implantable device within the outer tubular member. The pusher can include a slot to accommodate a suture binding mechanism of the implantable device. The delivery device can include a tip disposed at a distal end. The tip includes a tip transition zone. The inner sheath and outer tubular member can each have sections of distinct rigidity along their lengths with transition zones between the sections. A transition zone of the outer tubular member and a transition zone of the inner sheath can be longitudinally offset.",MERIT MEDICAL SYSTEMS INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;GILL BARTON;;GILL DARLA;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2015-09-30),https://lens.org/082-490-805-287-301,Granted Patent,yes,93,2,4,4,0,A61F2/966;;A61F2/915;;A61F2002/9665;;A61F2/966;;A61F2/915;;A61F2002/9665,A61F2/966;;A61F2/915,,43,0,,,"European Examination Report dated Feb. 18, 2015 for EP09791142.4.;;European Search Report dated Feb. 3, 2015 for EP12846255.3.;;European Search Report dated May 4, 2007 for EP05705271.4.;;International Preliminary Report dated May 15, 2014 for PCT/US2012/062603.;;International Publication and Search Report dated Jun. 14, 2012 for WO2012078794.;;International Publication and Search Report dated Feb. 25, 2012 for WO2010021836.;;International Publication and Search Report dated Aug. 4, 2005 for WO2005070095.;;International Search Report and Written Opinion dated Mar. 16, 2012 for PCT/US2011/063799.;;International Search Report and Written Opinion dated Mar. 29, 2013 for PCT/US2012/062603.;;International Search Report and Written Opinion dated Sep. 28, 2005 for PCT/US2005/000515.;;International Search Report and Written Opinion dated Oct. 29, 2009 for PCT/US2009/052691.;;International Search Report and Written Opinion dated Nov. 23, 2006 for PCT/US2006/018811.;;Notice of Allowance dated Jan. 14, 2015 for U.S. Appl. No. 11/432,964.;;Notice of Allowance dated Mar. 6, 2013 for U.S. Appl. No. 12/535,980.;;Notice of Allowance dated Jun. 11, 2013 for U.S. Appl. No. 10/585,430.;;Notice of Allowance dated Jun. 22, 2016 for U.S. Appl. No. 13/664,267.;;Notice of Allowance dated Aug. 12, 2015 for U.S. Appl. No. 13/664,200.;;Notice of Allowance dated Sep. 23, 2016 for U.S. Appl. No. 13/664,234.;;Notice of Allowance dated Oct. 21, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated Jan. 3, 2014 for U.S. Appl. No. 11/432,964.;;Office Action dated Jan. 22, 2013 for U.S. Appl. No. 10/585,430.;;Office Action dated Jan. 31, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Mar. 16, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 22, 2016 for U.S. Appl. No. 13/664,234.;;Office Action dated Mar. 24, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Apr. 6, 2016 for U.S. Appl. No. 13/664,137.;;Office Action dated May 5, 2014 for U.S. Appl. No. 13/313,929.;;Office Action dated May 25, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated Jun. 7, 2011 for U.S. Appl. No. 10/585,430.;;Office Action dated Jul. 9, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Jul. 25, 2013 for U.S. Appl. No. 11/432,964.;;Office Action dated Aug. 13, 2012 for U.S. Appl. No. 10/585,430.;;Office Action dated Oct. 7, 2015 for U.S. Appl. No. 13/664,234.;;Office Action dated Oct. 16, 2015 for U.S. Appl. No. 13/664,267.;;Office Action dated Nov. 9, 2010 for U.S. Appl. No. 10/585,430.;;Office Action dated Nov. 14, 2012 for U.S. Appl. No. 12/535,980.;;Office Action dated Nov. 19, 2015 for U.S. Appl. No. 13/664,137.;;Office Action dated Nov. 30, 2016 for U.S. Appl. No. 13/664,137.;;Office Action dated Dec. 7, 2009 for U.S. Appl. No. 11/432,964.;;Office Action dated Dec. 8, 2009 for U.S. Appl. No. 10/585,430.;;Supplementary European Search Report dated May 4, 2007 for EP05705271.4.;;Sen, et al., “Laplace's Equation for Convective Scalar Transport in Potential Flow”, Proc. R. Soc. Lond. A 456, pp. 3041-3045, 2000.;;European Search Report dated Jun. 30, 2017 for EP11846358.7.",ACTIVE
33,US,A1,US 2020/0146860 A1,002-476-001-113-071,2020-05-14,2020,US 201916679680 A,2019-11-11,US 201916679680 A;;US 201615263741 A;;US 201562218892 P,2015-09-15,IMPLANTABLE DEVICE DELIVERY SYSTEM,"Delivery systems and methods for deploying an implantable device are disclosed, which can include a delivery device having an outer tubular member and an inner assembly. The inner assembly is disposed within and is slidably movable relative to the outer tubular member. The inner assembly can include a pusher at a distal portion. The pusher abuts and restricts proximal movement, relative to the inner assembly, of a crimped implantable device within the outer tubular member. The pusher can include a slot to accommodate a suture binding mechanism of the implantable device. The delivery device can include a tip disposed at a distal end. The tip includes a tip transition zone. The inner sheath and outer tubular member can each have sections of distinct rigidity along their lengths with transition zones between the sections. A transition zone of the outer tubular member and a transition zone of the inner sheath can be longitudinally offset.",MERIT MEDICAL SYSTEM INC,ELLER ZEKE;;ROBINSON THOMAS PATRICK;;GILL BARTON;;GILL DARLA;;ELWOOD BRYAN K,MERIT MEDICAL SYSTEMS INC (2015-09-30),https://lens.org/002-476-001-113-071,Patent Application,yes,0,0,4,4,0,A61F2/966;;A61F2/915;;A61F2002/9665;;A61F2/966;;A61F2/915;;A61F2002/9665,A61F2/966,,0,0,,,,ACTIVE
34,US,S,US D0376424 S,052-592-100-010-774,1996-12-10,1996,US 041457,1995-07-14,,,Bottle,,,Macauley; Richard P.;;McCallister; Patrick E.;;Smithberger; Jay A.;;Sita; Lewis H.;;Stokesbury; Elwood L.,,https://lens.org/052-592-100-010-774,Design Right,yes,20,8,1,1,0,,,D24121;;D9520;;D24224,0,0,,,,UNKNOWN
35,US,S,US D0372090 S,125-535-167-259-06X,1996-07-23,1996,US 2612994 F,1994-07-20,US 2612994 F,1994-07-20,Bottle,,ABBOTT LAB,MACCAULEY RICHARD P;;MCCALLISTER PATRICK E;;SMITHBERGER JAY A;;SITA LEWIS H;;STOKESBURY ELWOOD L,ABBOTT LABORATORIES (1994-07-19),https://lens.org/125-535-167-259-06X,Design Right,yes,22,21,2,2,0,,,D24/121,0,0,,,,EXPIRED
36,US,S,US D0407817 S,085-133-379-771-187,1999-04-06,1999,US 4126895 F,1995-07-10,US 4126895 F,1995-07-10,Bottle and closure,,ABBOTT LAB,MACAULEY RICHARD PETER;;MCCALLISTER PATRICK EDWARD;;SMITHBERGER JAY ANDREW;;SITA LEWIS HENRY;;STOKESBURY ELWOOD LAMAR,ABBOTT LABORATORIES (1994-07-13),https://lens.org/085-133-379-771-187,Design Right,yes,24,6,1,1,0,,,D24/121;;2404,0,0,,,,EXPIRED
37,US,S,US D0372531 S,030-148-990-401-347,1996-08-06,1996,US 2613294 F,1994-07-20,US 2613294 F,1994-07-20,Combined bottle and cap,,ABBOTT LAB,MACAULEY RICHARD P;;MCCALLISTER PATRICK E;;SMITHBERGER JAY A;;SITA LEWIS H;;STOKESBURY ELWOOD L,ABBOTT LABORATORIES (1994-07-19),https://lens.org/030-148-990-401-347,Design Right,yes,25,1,1,1,0,,,D24/121,0,0,,,,EXPIRED
38,EP,A3,EP 1104704 A3,069-661-545-194-047,2001-07-11,2001,EP 00204056 A,2000-11-17,US 45178699 A,1999-12-01,Ink jet recording element,"An ink jet recording element comprising a substrate having thereon an image-receiving layer comprising an inorganic, anionic pigment, an organic, anionic binder and an organic, cationic mordant.",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE MARIE;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/069-661-545-194-047,Search Report,yes,3,0,4,4,0,B41M5/52;;B41M5/5218;;B41M5/5245;;B41M5/5254;;B41M5/5281;;B41M5/52;;B41M5/5254;;B41M5/5245;;B41M5/5281;;B41M5/5218,B41M5/00;;B41J2/01;;B41M5/50;;B41M5/52,,0,0,,,,DISCONTINUED
39,EP,A2,EP 1104704 A2,178-318-394-927-760,2001-06-06,2001,EP 00204056 A,2000-11-17,US 45178699 A,1999-12-01,Ink jet recording element,"An ink jet recording element comprising a substrate having thereon an image-receiving layer comprising an inorganic, anionic pigment, an organic, anionic binder and an organic, cationic mordant.",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE MARIE;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/178-318-394-927-760,Patent Application,yes,0,0,4,4,0,B41M5/52;;B41M5/52;;B41M5/5218;;B41M5/5218;;B41M5/5245;;B41M5/5245;;B41M5/5254;;B41M5/5254;;B41M5/5281;;B41M5/5281,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52,,0,0,,,,DISCONTINUED
40,EP,B1,EP 1104705 B1,001-686-134-233-551,2004-09-29,2004,EP 00204057 A,2000-11-17,US 45180999 A,1999-12-01,Method of preparing a stable coating for a pigment- coated inkjet recording element,,EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE MARIE;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/001-686-134-233-551,Granted Patent,yes,3,0,7,7,0,B41M5/5218;;B41M5/5245;;B41M5/5254;;C08L25/02;;C08L25/18;;C08L2205/02;;C09D125/10;;C09D125/14;;C09D129/04;;C09D125/14;;B41M5/5218;;C08L25/18;;C08L2205/02;;C08L25/02;;C09D125/10;;B41M5/5254;;C09D129/04;;B41M5/5245,B41M5/00;;B41M5/50;;B41J2/01;;B41M5/52;;C08L25/02;;C08L25/18;;C09D7/12;;C09D125/10;;C09D125/14;;C09D129/04;;C09D201/00,,0,0,,,,EXPIRED
41,DE,T2,DE 60005465 T2,067-353-002-098-238,2004-07-01,2004,DE 60005465 T,2000-11-20,US 45239699 A,1999-12-01,Tintenstrahldruckverfahren,,EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK J;;SAMONS ELWOOD C;;MOLLON CRAIG TH,,https://lens.org/067-353-002-098-238,Granted Patent,no,0,0,5,5,0,B41M5/52;;B41M5/5218;;B41M5/5245;;B41M5/5254;;B41M5/5281,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52,,0,0,,,,EXPIRED
42,EP,A1,EP 1106377 A1,012-163-714-154-979,2001-06-13,2001,EP 00204111 A,2000-11-20,US 45239699 A,1999-12-01,Ink jet printing method,"An ink jet printing method comprising the steps of:
 a) providing an ink jet printer that is responsive to digital data signals; b) loading the printer with an ink jet recording element comprising a substrate having thereon an image-receiving layer comprising an inorganic, anionic pigment, an organic, anionic binder and an organic, cationic mordant; c) loading the printer with an ink jet ink composition; and d) printing on the recording element using the ink jet ink in response to the digital data signals.",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK J;;SAMONS ELWOOD C;;MOLLON CRAIG TH,,https://lens.org/012-163-714-154-979,Patent Application,yes,3,2,5,5,0,B41M5/52;;B41M5/5218;;B41M5/5245;;B41M5/5254;;B41M5/5281,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1998, no. 13 30 November 1998 (1998-11-30)",EXPIRED
43,DE,D1,DE 60014300 D1,074-635-853-263-464,2004-11-04,2004,DE 60014300 T,2000-11-17,US 45180999 A,1999-12-01,Herstellungsverfahren einer stabilen Beschichtungszusammensetzung für ein mit Pigment beschichtetes Tintenstrahlaufzeichnungselement,,EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE MARIE;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/074-635-853-263-464,Granted Patent,no,0,0,7,7,0,B41M5/5218;;B41M5/5245;;B41M5/5254;;C08L25/02;;C08L25/18;;C08L2205/02;;C09D125/10;;C09D125/14;;C09D129/04;;C09D125/14;;B41M5/5218;;C08L25/18;;C08L2205/02;;C08L25/02;;C09D125/10;;B41M5/5254;;C09D129/04;;B41M5/5245,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52;;C08L25/02;;C08L25/18;;C09D7/12;;C09D125/10;;C09D125/14;;C09D129/04;;C09D201/00,,0,0,,,,EXPIRED
44,JP,A,JP 2001205930 A,173-084-393-273-549,2001-07-31,2001,JP 2000364596 A,2000-11-30,US 45178699 A,1999-12-01,INK JET RECORDING ELEMENT,"PROBLEM TO BE SOLVED: To provide an ink jet recording element, in which the drying time of ink is short and the picture quality of which is favorable. SOLUTION: This ink jet recording element is produced by having an image acceptable layer including an anionic inorganic pigment, an anionic organic binder and a cationic organic mordant on a support.",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/173-084-393-273-549,Patent Application,no,0,0,4,4,0,B41M5/52;;B41M5/52;;B41M5/5218;;B41M5/5218;;B41M5/5245;;B41M5/5245;;B41M5/5254;;B41M5/5254;;B41M5/5281;;B41M5/5281,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52,,0,0,,,,PENDING
45,JP,A,JP 2001247825 A,029-916-068-255-388,2001-09-14,2001,JP 2000366935 A,2000-12-01,US 45180999 A,1999-12-01,METHOD FOR MANUFACTURING STABLE COATING AGENT,"PROBLEM TO BE SOLVED: To obtain a stable coating agent containing a cationic mordant, an anionic pigment, and an anionic binder, and keeping a constant viscosity which enables coating with a standard technology. SOLUTION: This is a manufacturing method of a coating agent comprising an inorganic anionic pigment, an organic anionic binder, and an organic cationic mordant comprises following processes, (a) mixing the inorganic anionic pigment with the organic cationic mordent, (b) lowering the pH of the mixture to lower than 4; and (c) addition of the organic anionic binder to the mixture. Thus, a coating composition having nearly a constant viscosity for a certain period of time is obtained.",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/029-916-068-255-388,Patent Application,no,0,0,7,7,0,B41M5/5218;;B41M5/5245;;B41M5/5254;;C08L25/02;;C08L25/18;;C08L2205/02;;C09D125/10;;C09D125/14;;C09D129/04;;C09D125/14;;B41M5/5218;;C08L25/18;;C08L2205/02;;C08L25/02;;C09D125/10;;B41M5/5254;;C09D129/04;;B41M5/5245,B41M5/00;;B41M5/50;;B41M5/52;;C08L25/02;;B41J2/01;;C08L25/18;;C09D7/12;;C09D125/10;;C09D125/14;;C09D129/04;;C09D201/00,,0,0,,,,PENDING
46,JP,A,JP 2001199159 A,036-102-785-748-493,2001-07-24,2001,JP 2000364679 A,2000-11-30,US 45239699 A,1999-12-01,INK JET PRINTING METHOD,"PROBLEM TO BE SOLVED: To provide an ink jet printing method, employing a recording element having a quick ink drying time and an excellent quality of image. SOLUTION: The ink jet printing method comprises a) the preparing process of an ink jet printer, responding to a digital data signal, b) the loading process of the ink jet recording element constituted of a substrate, carrying an image receptor layer comprising an inorganic anionic pigment, an organic anionic binder and an organic cationic mordant, on the printer, c) the loading process of an ink jet ink composite on the printer, and d) printing process on the recording element employing the ink jet ink while responding to the digital data signal.",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/036-102-785-748-493,Patent Application,no,0,0,5,5,0,B41M5/52;;B41M5/5218;;B41M5/5245;;B41M5/5254;;B41M5/5281,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52,,0,0,,,,PENDING
47,EP,A2,EP 1104705 A2,051-728-613-830-704,2001-06-06,2001,EP 00204057 A,2000-11-17,US 45180999 A,1999-12-01,Method of preparing a stable coating for a pigment- coated inkjet recording element,"A process for making a stable coating comprising an inorganic, anionic pigment, an organic, anionic binder and an organic, cationic mordant comprising:
 a) mixing the inorganic, anionic pigment with the organic, cationic mordant; b) lowering the pH of the mixture to below 4; and c) adding the organic, anionic binder to the mixture,  thus providing a coating composition which has an approximately constant viscosity over a period of time.",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE MARIE;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/051-728-613-830-704,Patent Application,yes,0,0,7,7,0,B41M5/5218;;B41M5/5245;;B41M5/5254;;C08L25/02;;C08L25/18;;C08L2205/02;;C09D125/10;;C09D125/14;;C09D129/04;;C09D125/14;;B41M5/5218;;C08L25/18;;C08L2205/02;;C08L25/02;;C09D125/10;;B41M5/5254;;C09D129/04;;B41M5/5245,B41M5/00;;B41M5/50;;B41J2/01;;B41M5/52;;C08L25/02;;C08L25/18;;C09D7/12;;C09D125/10;;C09D125/14;;C09D129/04;;C09D201/00,,0,0,,,,EXPIRED
48,EP,B1,EP 1106377 B1,163-038-719-008-340,2003-09-24,2003,EP 00204111 A,2000-11-20,US 45239699 A,1999-12-01,Ink jet printing method,,EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK J;;SAMONS ELWOOD C;;MOLLON CRAIG TH,,https://lens.org/163-038-719-008-340,Granted Patent,yes,3,0,5,5,0,B41M5/52;;B41M5/5218;;B41M5/5245;;B41M5/5254;;B41M5/5281,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1998, no. 13, 30 November 1998 (1998-11-30) & JP 10 217601 A (KONICA CORP), 18 August 1998 (1998-08-18)",EXPIRED
49,DE,D1,DE 60005465 D1,172-431-999-868-069,2003-10-30,2003,DE 60005465 T,2000-11-20,US 45239699 A,1999-12-01,Tintenstrahldruckverfahren,,EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK J;;SAMONS ELWOOD C;;MOLLON CRAIG TH,,https://lens.org/172-431-999-868-069,Granted Patent,no,0,0,5,5,0,B41M5/52;;B41M5/5218;;B41M5/5245;;B41M5/5254;;B41M5/5281,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52,,0,0,,,,EXPIRED
50,US,B1,US 6271048 B1,168-546-050-248-088,2001-08-07,2001,US 69342800 A,2000-10-20,US 69342800 A,2000-10-20,Process for recycling a substrate from an integrated circuit package,"An integrated circuit package is processed by a grinding step, a dissolving step, and a disintegrating step. The grinding step grinds an IC-chip completely off of a substrate, and it also grinds a first portion of a filler layer and a first portion of a set of solder balls which attach the IC-chip to the substrate. This leaves a partial filler layer and partial solder balls on the substrate. The dissolving step dissolves the partial filler layer off of the substrate after the grinding step; and the disintegration step disintegrates at least part of each partial solder ball by subjecting the partial solder balls on the substrate to ultrasonic vibration after the dissolving step. These steps leave the substrate with small solder mounds that can be easily attached to another IC-chip with another set of solder balls.",UNISYS CORP,REILICH KENNETH PATRICK;;NORELL RONALD ALLEN;;PREECHA ELVIRA WIDYANI;;WING JOEL ELWOOD;;WING LORRAINE LO-LAN,UNISYS CORPORATION (2000-10-20),https://lens.org/168-546-050-248-088,Granted Patent,yes,10,12,1,1,0,H01L24/11;;H01L24/81;;H01L2224/13099;;H01L2224/13111;;H01L2224/16;;H01L2224/73253;;H01L2224/81801;;H01L2924/01027;;H01L2924/01079;;H01L2924/01082;;H01L2924/01327;;H01L2924/14;;H01L2924/15174;;H01L2924/16152;;H01L2924/19041;;H01L2924/19043;;H01L2924/01005;;H01L2924/01006;;H01L2924/01023;;H01L2924/01033;;H01L2924/0105;;H01L2924/014;;H01L2924/15787;;H01L2224/05573;;H01L2224/05568;;H01L2924/00014;;H01L24/81;;H01L2224/16;;H01L2224/13111;;H01L24/11;;H01L2924/01082;;H01L2924/01327;;H01L2924/15174;;H01L2924/01079;;H01L2924/19041;;H01L2924/19043;;H01L2924/01027;;H01L2224/81801;;H01L2224/13099;;H01L2224/73253;;H01L2924/14;;H01L2924/16152;;H01L2924/01005;;H01L2924/01033;;H01L2924/01023;;H01L2924/0105;;H01L2924/01006;;H01L2924/014;;H01L2924/15787;;H01L2224/05568;;H01L2224/05573;;H01L2924/00014,H01L21/60,438/14;;438/105;;438/106;;438/117,0,0,,,,EXPIRED
51,DE,T2,DE 60014300 T2,102-257-333-243-433,2006-02-16,2006,DE 60014300 T,2000-11-17,US 45180999 A,1999-12-01,Herstellungsverfahren einer stabilen Beschichtungszusammensetzung für ein mit Pigment beschichtetes Tintenstrahlaufzeichnungselement,,EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE MARIE;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/102-257-333-243-433,Granted Patent,no,0,0,7,7,0,B41M5/5218;;B41M5/5245;;B41M5/5254;;C08L25/02;;C08L25/18;;C08L2205/02;;C09D125/10;;C09D125/14;;C09D129/04;;C09D125/14;;B41M5/5218;;C08L25/18;;C08L2205/02;;C08L25/02;;C09D125/10;;B41M5/5254;;C09D129/04;;B41M5/5245,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52;;C08L25/02;;C08L25/18;;C09D7/12;;C09D125/10;;C09D125/14;;C09D125/18;;C09D129/04;;C09D201/00,,0,0,,,,EXPIRED
52,US,B1,US 6335395 B1,074-012-518-674-29X,2002-01-01,2002,US 45180999 A,1999-12-01,US 45180999 A,1999-12-01,Method of preparing a stable coating,"
    A process for making a stable coating comprising an inorganic, anionic pigment, an organic, anionic binder and an organic, cationic mordant comprising: 

    a) mixing the inorganic, anionic pigment with the organic, cationic mordant; 

    b) lowering the pH of the mixture to below about 4; and 

    c) adding the organic, anionic binder to the mixture, 

    thus providing a coating composition which has an approximately constant viscosity over a period of time. 
",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK J;;SAMONS ELWOOD C;;MOLLON CRAIG T,EASTMAN KODAK COMPANY (1999-11-30),https://lens.org/074-012-518-674-29X,Granted Patent,yes,9,8,7,7,0,B41M5/5218;;B41M5/5245;;B41M5/5254;;C08L25/02;;C08L25/18;;C08L2205/02;;C09D125/10;;C09D125/14;;C09D129/04;;C09D125/14;;B41M5/5218;;C08L25/18;;C08L2205/02;;C08L25/02;;C09D125/10;;B41M5/5254;;C09D129/04;;B41M5/5245,B41M5/00;;B41J2/01;;B41M5/50;;B41M5/52;;C08L25/02;;C08L25/18;;C09D7/12;;C09D125/10;;C09D125/14;;C09D129/04;;C09D201/00,524/445;;524/446;;524/447;;524/451;;524/492;;524/493;;524/497;;524/494;;524/551;;524/555;;524/556;;524/563;;524/557;;524/577;;524/575,0,0,,,,EXPIRED
53,EP,A3,EP 1104705 A3,159-740-012-378-546,2001-08-29,2001,EP 00204057 A,2000-11-17,US 45180999 A,1999-12-01,Method of preparing a stable coating for a pigment- coated inkjet recording element,"A process for making a stable coating comprising an inorganic, anionic pigment, an organic, anionic binder and an organic, cationic mordant comprising: a) mixing the inorganic, anionic pigment with the organic, cationic mordant; b) lowering the pH of the mixture to below 4; and c) adding the organic, anionic binder to the mixture,  thus providing a coating composition which has an approximately constant viscosity over a period of time. The stable coating is used for a pigment-coated inkjet recording element.",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE MARIE;;WHITTAKER PATRICK JAMES;;SAMONS ELWOOD C;;MOLLON CRAIG THOMAS,,https://lens.org/159-740-012-378-546,Search Report,yes,3,0,7,7,0,B41M5/5218;;B41M5/5245;;B41M5/5254;;C08L25/02;;C08L25/18;;C08L2205/02;;C09D125/10;;C09D125/14;;C09D129/04;;C09D125/14;;B41M5/5218;;C08L25/18;;C08L2205/02;;C08L25/02;;C09D125/10;;B41M5/5254;;C09D129/04;;B41M5/5245,B41M5/00;;B41M5/50;;B41J2/01;;B41M5/52;;C08L25/02;;C08L25/18;;C09D7/12;;C09D125/10;;C09D125/14;;C09D129/04;;C09D201/00,,0,0,,,,EXPIRED
54,US,B1,US 6632486 B1,174-295-566-416-883,2003-10-14,2003,US 45178699 A,1999-12-01,US 45178699 A,1999-12-01,Ink jet recording element,"
    An ink jet recording element comprising a substrate having thereon an image-receiving layer comprising an inorganic, anionic pigment, an organic, anionic binder and an organic, cationic mordant. 
",EASTMAN KODAK CO,SADASIVAN SRIDHAR;;SUNDERRAJAN SURESH;;OAKLAND MICHELLE M;;WHITTAKER PATRICK J;;SAMONS ELWOOD C;;MOLLON CRAIG T,EASTMAN KODAK COMPANY (1999-11-30),https://lens.org/174-295-566-416-883,Granted Patent,yes,12,2,4,4,0,B41M5/52;;B41M5/52;;B41M5/5218;;B41M5/5218;;B41M5/5245;;B41M5/5245;;B41M5/5254;;B41M5/5254;;B41M5/5281;;B41M5/5281,B41J2/01;;B41M5/00;;B41M5/50;;B41M5/52,428/32.15;;428/32.3;;428/32.29;;428/32.34,0,0,,,,EXPIRED
55,AU,A1,AU 2014/278524 A1,040-745-977-064-911,2015-12-24,2015,AU 2014/278524 A,2014-06-06,US 201361833268 P;;US 2014/0041282 W,2013-06-10,Preserved microwavable food products,"A microwavable tray containing a preserved, such as frozen, preferably liquid, food product. The tray can be capable of being folded at least in half and closed after microwaving. The liquid food product contained in the tray has the consistency and texture after microwaving of freshly prepared product, allowing it to be folded at least in half when the tray is folded, or even without a folding tray. During the microwave process, various fillings can be added to the product ether frozen or unfrozen prior to folding.",HEINZ CO BRANDS H J LLC,SMITH KATHERINE ANNE;;HUBER BRIAN;;ROWOTH CHRISTOPHER P;;RITCHEY BETH A;;CARMAN BRIAN PATRICK;;JACKSON DANIEL C;;MATTHEWS JAMES ELWOOD,,https://lens.org/040-745-977-064-911,Patent Application,no,0,0,4,4,0,A23B5/043;;A23L3/36;;A23L3/36;;A23L3/364;;A23L5/34;;A23L5/34;;A23L15/00;;A23L15/00;;A23V2002/00;;B65D81/3453;;B65D81/3453;;B65D43/162;;B65D43/162,A23B7/148,,0,0,,,,DISCONTINUED
56,US,A1,US 2016/0122118 A1,017-834-279-602-103,2016-05-05,2016,US 201414897243 A,2014-06-06,US 201414897243 A;;US 201361833268 P;;US 2014/0041282 W,2013-06-10,Preserved Microwavable Food Products,"A microwavable tray containing a preserved, such as frozen, preferably liquid, food product. The tray can be capable of being folded at least in half and closed after microwaving. The liquid food product contained in the tray has the consistency and texture after microwaving of freshly prepared product, allowing it to be folded at least in half when the tray is folded, or even without a folding tray. During the microwave process, various fillings can be added to the product ether frozen or unfrozen prior to folding.",HEINZ CO BRANDS H J LLC,SMITH KATHERINE ANNE;;HUBER BRIAN;;ROWOTH CHRISTOPHER P;;RITCHEY BETH A;;CARMAN BRIAN PATRICK;;JACKSON DANIEL C;;MATTHEWS JAMES ELWOOD,,https://lens.org/017-834-279-602-103,Patent Application,yes,2,1,4,4,0,A23B5/043;;A23L3/36;;A23L3/36;;A23L3/364;;A23L5/34;;A23L5/34;;A23L15/00;;A23L15/00;;A23V2002/00;;B65D81/3453;;B65D81/3453;;B65D43/162;;B65D43/162,B65D81/34;;A23B5/04;;A23L3/36,,0,0,,,,DISCONTINUED
57,WO,A1,WO 2014/200847 A1,142-427-697-734-487,2014-12-18,2014,US 2014/0041282 W,2014-06-06,US 201361833268 P,2013-06-10,PRESERVED MICROWAVABLE FOOD PRODUCTS,"A microwavable tray containing a preserved, such as frozen, preferably liquid, food product. The tray can be capable of being folded at least in half and closed after microwaving. The liquid food product contained in the tray has the consistency and texture after microwaving of freshly prepared product, allowing it to be folded at least in half when the tray is folded, or even without a folding tray. During the microwave process, various fillings can be added to the product ether frozen or unfrozen prior to folding.",HEINZ CO H J,SMITH KATHERINE ANNE;;HUBER BRIAN;;ROWOTH CHRISTOPHER P;;RITCHEY BETH A;;CARMAN BRIAN PATRICK;;JACKSON DANIEL C;;MATTHEWS JAMES ELWOOD,,https://lens.org/142-427-697-734-487,Patent Application,yes,5,1,4,4,0,A23B5/043;;A23L3/36;;A23L3/36;;A23L3/364;;A23L5/34;;A23L5/34;;A23L15/00;;A23L15/00;;A23V2002/00;;B65D81/3453;;B65D81/3453;;B65D43/162;;B65D43/162,A23B7/148,,0,0,,,,PENDING
58,EP,A1,EP 3007562 A1,088-901-839-946-565,2016-04-20,2016,EP 14811330 A,2014-06-06,US 201361833268 P;;US 2014/0041282 W,2013-06-10,PRESERVED MICROWAVABLE FOOD PRODUCTS,,HEINZ CO BRANDS H J LLC,SMITH KATHERINE ANNE;;HUBER BRIAN;;ROWOTH CHRISTOPHER P;;RITCHEY BETH A;;CARMAN BRIAN PATRICK;;JACKSON DANIEL C;;MATTHEWS JAMES ELWOOD,,https://lens.org/088-901-839-946-565,Patent Application,yes,0,0,4,4,0,A23B5/043;;A23L3/36;;A23L3/36;;A23L3/364;;A23L5/34;;A23L5/34;;A23L15/00;;A23L15/00;;A23V2002/00;;B65D81/3453;;B65D81/3453;;B65D43/162;;B65D43/162,A23B7/148,,1,0,,,See references of WO 2014200847A1,DISCONTINUED
59,AT,T1,AT E413386 T1,133-979-155-146-890,2008-11-15,2008,AT 99901492 T,1999-01-20,US 7304298 P,1998-01-29,PPAR-GAMMA MODULATOREN,,AMGEN INC,DE LA BROUSE-ELWOOD FABIENNE;;JAEN JUAN;;MCGEE LAWRENCE;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN;;CHEN JIN-LONG;;CUSHING TIMOTHY;;FLYGARE JOHN;;HOUZE JONATHAN;;KEARNEY PATRICK,,https://lens.org/133-979-155-146-890,Granted Patent,no,0,0,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,0,0,,,,EXPIRED
60,CA,C,CA 2318731 C,068-480-122-789-138,2012-05-29,2012,CA 2318731 A,1999-01-20,US 7304298 P;;US 9901147 W,1998-01-29,PPAR-GAMMA MODULATORS,"Modulators of PPAR.gamma. activity are provided having formula (I): in which the symbol Ar represents an aryl group; the letter X represents a divalent linkage selected from the group consisting of =C1-C6alkylene, -(C1-C6)alkylenoxy, -O-, -C(O)-, -N(R11)-, -N(R11)C(O)-, -S(O)k- and a single bond, in which R11 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, and arylalkyl and the subscript k is an integer of from 0 to 2. The letter Y, in formula (I) represents a divalent linkage selected from the group consisting of alkylene, -O-, -C(O)-, -N(R12)-S(O)m-, -N(R13)-S(O)m-N(R13)-, -N(R12)C(O)-, -S(O)n-, a single bond, and combinations thereof in which R12 and R13 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscripts m and n independently integers of from 0 to 2. The symbol R1 represents a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, arylalkyl, -CO2R14, -CO(R)14, -C(O)NR15R16, -S(O)p-R14, -S(O)q-NR15R16, -O-C(O)-OR17, -O-C(O)-R17, -O-C(O)-NR15R16, -N(R14)-C(O)-NR15R16, -N(R14)-C(O)-R17 and -N(R14)-C(O)-OR17, in which R14 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl, and R15 and R16 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl, or taken together with the nitrogen to which each is attached from a 5-, 6- or 7-membered ring. The symbol R17 represents a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl. Additionally, for the R1 groups described above, the subscript p is an integer of from 0 to 3, and the subscript q is an integer of from 1 to 2. The symbol R2 represents a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl. In another aspect, the present invention provides compounds of formula (I), as well as pharmaceutical compositions containing the compounds described above for the treatment of conditions such as type II diabetes and obesity.",TULARIK INC,DE LA BROUSSE-ELWOOD FABIENNE;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;KEARNEY PATRICK C,,https://lens.org/068-480-122-789-138,Granted Patent,no,0,0,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,C07D213/65;;A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/435;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/643;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D239/34;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,0,0,,,,EXPIRED
61,DE,D1,DE 69939864 D1,087-394-630-226-217,2008-12-18,2008,DE 69939864 T,1999-01-20,US 7304298 P;;US 9901147 W,1998-01-29,PPAR-GAMMA MODULATOREN,,AMGEN INC,DE LA BROUSE-ELWOOD FABIENNE;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;KEARNEY PATRICK C,,https://lens.org/087-394-630-226-217,Granted Patent,no,0,0,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,C07D213/65;;A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/435;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/643;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D239/34;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,0,0,,,,EXPIRED
62,US,B1,US 6200995 B1,184-981-367-438-687,2001-03-13,2001,US 23432799 A,1999-01-20,US 23432799 A;;US 7304298 P,1998-01-29,PPAR-gamma modulators,Modulators of PPAR.gamma. activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.,TULARIK INC,DE LA BROUSE-ELWOOD FABIENNE;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;KEARNEY PATRICK C,TULARIK INC (1999-03-25);;AMGEN SF LLC (2004-08-13);;AMGEN INC (2005-06-17),https://lens.org/184-981-367-438-687,Granted Patent,yes,46,142,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,514/347;;546/294;;546/295;;514/345;;514/351,2,0,,,"Chemical Abstracts, vol. 67, No. 9, Aug. 28, 1967 Columbus Ohio; abstract No. 43516y, p. 4076; XP002099084 & I. BADILESCU: ""Synthesis of some N-aryl-and N,N-dialkyl-p-chloro-benzenesulfonamides"" Rev. Chim. (Bucharest) vol. 17, No. 11, 1966, pp. 705-706, see abstract.;;Chemical Abstracts, vol. 67, No. 9, Aug. 28, 1967, Columbus, Ohio, United States; abstract No. 43516y, p. 4076; XP002099084; & I. Badilescu: ""Synthesis of some N-aryl-and N,N-dialkyl-p-chloro-benzensulfonamides"" Rev.Chim., vol. 17, No. 11, 1966, pp. 705-706.",EXPIRED
63,AU,A,AU 1999/021176 A,112-601-957-560-237,1999-08-16,1999,AU 1999/021176 A,1999-01-20,US 7304298 P;;US 9901147 W,1998-01-29,Ppar-gamma modulators,,AMGEN INC,BROUSE-ELWOOD FABIENNE DE LA;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;KEARNEY PATRICK C,,https://lens.org/112-601-957-560-237,Patent Application,no,0,0,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,0,0,,,,EXPIRED
64,US,A1,US 2001/0027200 A1,191-857-014-830-224,2001-10-04,2001,US 74141500 A,2000-12-19,US 74141500 A;;US 23432799 A;;US 7304298 P,1998-01-29,PPARgamma modulators,"
   Modulators of PPAR activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity. 
",TULARIK INC,DE LA BROUSE-ELWOOD FABIENNE;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;KEARNEY PATRICK C,AMGEN SF LLC (2004-08-13);;AMGEN INC (2005-06-17),https://lens.org/191-857-014-830-224,Patent Application,yes,0,58,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,514/336;;514/345;;X54629;;546/268.4,0,0,,,,EXPIRED
65,EP,A1,EP 1053227 A1,138-712-036-327-321,2000-11-22,2000,EP 99901492 A,1999-01-20,US 9901147 W;;US 7304298 P,1998-01-29,PPAR-GAMMA MODULATORS,,TULARIK INC,DE LA BROUSE-ELWOOD FABIENNE;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;KEARNEY PATRICK C,AMGEN INC. (2006-04-26),https://lens.org/138-712-036-327-321,Patent Application,yes,0,0,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,0,0,,,,EXPIRED
66,CA,A1,CA 2318731 A1,017-342-376-222-70X,1999-08-05,1999,CA 2318731 A,1999-01-20,US 7304298 P;;US 9901147 W,1998-01-29,PPAR-GAMMA MODULATORS,"Modulators of PPAR.gamma. activity are provided having formula (I): in which the symbol Ar represents an aryl group; the letter X represents a divalent linkage selected from the group consisting of =C1-C6alkylene, -(C1-C6)alkylenoxy, -O-, -C(O)-, -N(R11)-, -N(R11)C(O)-, -S(O)k- and a single bond, in which R11 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, and arylalkyl and the subscript k is an integer of from 0 to 2. The letter Y, in formula (I) represents a divalent linkage selected from the group consisting of alkylene, -O-, -C(O)-, -N(R12)-S(O)m-, -N(R13)-S(O)m-N(R13)-, -N(R12)C(O)-, -S(O)n-, a single bond, and combinations thereof in which R12 and R13 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscripts m and n independently integers of from 0 to 2. The symbol R1 represents a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, arylalkyl, -CO2R14, -CO(R)14, -C(O)NR15R16, -S(O)p-R14, -S(O)q-NR15R16, -O-C(O)-OR17, -O-C(O)-R17, -O-C(O)-NR15R16, -N(R14)-C(O)-NR15R16, -N(R14)-C(O)-R17 and -N(R14)-C(O)-OR17, in which R14 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl, and R15 and R16 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl, or taken together with the nitrogen to which each is attached from a 5-, 6- or 7-membered ring. The symbol R17 represents a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl. Additionally, for the R1 groups described above, the subscript p is an integer of from 0 to 3, and the subscript q is an integer of from 1 to 2. The symbol R2 represents a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl. In another aspect, the present invention provides compounds of formula (I), as well as pharmaceutical compositions containing the compounds described above for the treatment of conditions such as type II diabetes and obesity.",TULARIK INC,CUSHING TIMOTHY D;;MCGEE LAWRENCE R;;JAEN JUAN C;;DE LA BROUSE-ELWOOD FABIENNE;;HOUZE JONATHAN B;;MIAO SHI-CHANG;;CHEN JIN-LONG;;RUBENSTEIN STEVEN MARC;;KEARNEY PATRICK C;;FLYGARE JOHN A,,https://lens.org/017-342-376-222-70X,Patent Application,no,0,0,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,0,0,,,,EXPIRED
67,WO,A1,WO 1999/038845 A1,151-719-867-425-742,1999-08-05,1999,US 9901147 W,1999-01-20,US 7304298 P,1998-01-29,PPAR-GAMMA MODULATORS,"Modulators of PPARη activity are provided having formula (I): in which the symbol Ar represents an aryl group; the letter X represents a divalent linkage selected from the group consisting of =C1-C6alkylene, -(C1-C6)alkylenoxy, -O-, -C(O)-, -N(R11)-, -N(R11)C(O)-, -S(O)¿k?- and a single bond, in which R?11¿ is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, and arylalkyl and the subscript k is an integer of from 0 to 2. The letter Y, in formula (I) represents a divalent linkage selected from the group consisting of alkylene, -O-, -C(O)-, -N(R12)-S(O)¿m?-, -N(R?13¿)-S(O)¿m-N(R?13)-, -N(R12)C(O)-, -S(O)¿n?-, a single bond, and combinations thereof in which R?12 and R13¿ are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscripts m and n independently integers of from 0 to 2. The symbol R1 represents a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, arylalkyl, -CO¿2R?14, -CO(R)14, -C(O)NR15R16, -S(O)¿p-R?14, -S(O)¿q?-NR?15R16¿, -O-C(O)-OR17, -O-C(O)-R17, -O-C(O)-NR?15R16, -N(R14¿)-C(O)-NR?15R16, -N(R14¿)-C(O)-R17 and -N(R14)-C(O)-OR17, in which R14 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl, and R?15 and R16¿ are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl, or taken together with the nitrogen to which each is attached from a 5-, 6- or 7-membered ring. The symbol R17 represents a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl. Additionally, for the R1 groups described above, the subscript p is an integer of from 0 to 3, and the subscript q is an integer of from 1 to 2. The symbol R2 represents a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl. In another aspect, the present invention provides compounds of formula (I), as well as pharmaceutical compositions containing the compounds described above for the treatment of conditions such as type II diabetes and obesity.",TULARIK INC,DE LA BROUSE-ELWOOD FABIENNE;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;KEARNEY PATRICK C,,https://lens.org/151-719-867-425-742,Patent Application,yes,9,150,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,1,0,,,"CHEMICAL ABSTRACTS, vol. 67, no. 9, 28 August 1967, Columbus, Ohio, US; abstract no. 43516y, page 4076; XP002099084",PATENTED
68,AU,B2,AU 759255 B2,056-145-472-759-779,2003-04-10,2003,AU 1999/021176 A,1999-01-20,US 7304298 P;;US 9901147 W,1998-01-29,PPAR-gamma modulators,,TULARIK INC,BROUSE-ELWOOD FABIENNE DE LA;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;KEARNEY PATRICK C,,https://lens.org/056-145-472-759-779,Granted Patent,no,3,0,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,0,0,,,,EXPIRED
69,EP,B1,EP 1053227 B1,176-151-174-763-368,2008-11-05,2008,EP 99901492 A,1999-01-20,US 9901147 W;;US 7304298 P,1998-01-29,PPAR-GAMMA MODULATORS,,AMGEN INC,DE LA BROUSE-ELWOOD FABIENNE;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;KEARNEY PATRICK C,AMGEN INC. (2006-04-26),https://lens.org/176-151-174-763-368,Granted Patent,yes,9,0,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,C07D213/65;;A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/435;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/643;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D239/34;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,,1,0,,,"CHEMICAL ABSTRACTS, vol. 67, no. 9, 28 August 1967 Columbus, Ohio, US; abstract no. 43516y, page 4076; XP002099084 & I. BADILESCU: ""Synthesis of some N-aryl- and N,N-dialkyl-p-chloro-benzenesulfonamides"" REV. CHIM., vol. 17, no. 11, 1966, pages 705-6,",EXPIRED
70,US,B2,US 6620827 B2,070-700-522-495-263,2003-09-16,2003,US 74141500 A,2000-12-19,US 74141500 A;;US 23432799 A;;US 7304298 P,1998-01-29,PPARgamma modulators,"
    Modulators of PPAR activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity. 
",TULARIK INC,DE LA BROUSE-ELWOOD FABIENNE;;CHEN JIN-LONG;;CUSHING TIMOTHY D;;FLYGARE JOHN A;;HOUZE JONATHAN B;;JAEN JUAN C;;MCGEE LAWRENCE R;;MIAO SHI-CHANG;;RUBENSTEIN STEVEN MARC;;KEARNEY PATRICK C,AMGEN SF LLC (2004-08-13);;AMGEN INC (2005-06-17),https://lens.org/070-700-522-495-263,Granted Patent,yes,54,35,17,66,0,C07C311/21;;C07D213/65;;C07D213/70;;C07D215/20;;C07D217/04;;C07D405/12;;A61P3/04;;A61P43/00;;A61P3/10;;C07D213/70;;C07D217/04;;C07C311/21;;C07D405/12;;C07D215/20;;C07D213/65,A61K31/18;;A61K31/235;;A61K31/42;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4406;;A61K31/4427;;A61K31/443;;A61K31/4439;;A61K31/47;;A61K31/472;;A61K31/4965;;A61K31/497;;A61P3/04;;A61P3/10;;A61P43/00;;C07C311/21;;C07D213/61;;C07D213/65;;C07D213/70;;C07D213/71;;C07D213/89;;C07D215/20;;C07D217/04;;C07D233/70;;C07D233/84;;C07D401/12;;C07D405/12;;C07D413/12;;C07D417/12,514/347;;514/345;;514/351;;546/294;;546/295,2,0,,,"Chemical Abstracts, vol. 67, No. 9, Aug. 28, 1967, Columbus, Ohio, United States; abstract No. 43516y, p. 4076; XP002099084; & 1. Badilescu: ""Sythesis of some N-aryl- and N,N-dialkyl-p-chloro-benzensulfonamides"" Rev.Chim., vol. 17, No. 11, 1966, pp. 705-706.;;Chemical Abstracts, vol. 67, No. 9, Aug. 28, 1967 Columbus Ohio; abstract No. 43516y, p. 4076; XP002099084 & I. Badilescu: ""Synthesis of some N-aryl- and N,N-dialkyl-p-chloro-benzenesulfonamides"" Rev. Chim.(Bucharest) vol. 17, No. 11, 1966, pp. 705-706, see abstract.",EXPIRED
